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ABSTRACT 
This study examined the rates and  risks of premature neonates <2500grams developing 
intraoperative non-euglycemia events (IONEE).A retrospective chart review of 26 premature 
neonates <2500 grams who underwent surgical procedures between January 1 and December 31, 
2009 was conducted. Statistical analysis was done using Chi square and t-tests.  
Ten of the 26 subjects (38%) experienced an IONEE. Hyperglycemia was the primary 
IONEE that was noted in the neonates.  (Mean: 143.19; sd: 56.041)  Length of surgery was 
significantly longer in those premature neonates with IONEE than those with euglycemia (71.7 
0± 27.03 vs. 45.62 ± 17.98 minutes).  All IONEE subjects received general anesthesia (n=10) 
while none of those with only intravenous anesthesia had an IONEE (X2 (1) = 4.875, p=.027). 
Subjects with IONEE had a higher mean preoperative glucose level (127.11 gm/dL ± 31.66) than 
those who did not experienced IONEE (86.36 gm/dL ± 29.39; t(21) = 3.151, p=.005). A higher 
proportion of subjects who developed IONEE had the capillary heel (60%) as opposed to an 
arterial (40%) site for blood collection (X2 (1) = 6.518, p =.001). Also, subjects free of 
preoperative pulmonary complications were more prone to develop IONEE (X2 (1)= 8.60, p = 
.003). The presence of IONEE was associated with development of metabolic acidosis (X2
Anesthesia providers need to establish intraoperative guidelines for the monitoring and 
treatment of IONEE to protect these premature neonates from having complications such as 
developmental delay.
 (1)= 
5.426, p=.020) and lower postoperative pH values (7.19 ± 0.20 vs. 7.35 ± 0.11).  
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CHAPTER 1: INTRODUCTION 
Introduction 
With the preterm birth rate in the United States reaching 12.6% and the premature 
neonates with low birth weight (<2500 grams) rate rising to 8.7%, there is an increased need for 
health care providers to monitor and support the complex physiological needs of this vulnerable 
group (Hamilton, 2009). For purposes of this study, a premature neonate is defined as those 
neonates whose gestational age at birth is < 37 weeks. One critical physiological need is 
maintaining euglycemia (American Academy of Pediatrics, 2006; Karlsen, 2006; Kattwinkel, 
2006; Zaichkin, 2006). Preterm neonates have both limited glycogen stores and an immature 
insulin response, which makes maintaining euglycemia in this population difficult (Blanco, 
Baillargeon, Morrison, & Gong, 2006; Garg, Agthe, Donohue, & Lehmann, 2003; Heimann, et 
al., 2007; Kao, et al., 2006; Sharma, et al., 2009). Premature neonates experiencing recurrent 
non-euglycemic events (hyper- and hypoglycemia) are at increased risk for a number of adverse 
health outcomes including intraventricular hemorrhage, sepsis, and even premature death 
(Blanco, et al., 2006; Garg, et al., 2003; Heimann, et al., 2007; Kao, et al., 2006; Sharma, et al., 
2009). The risk for experiencing non-euglycemic events increases when preterm neonates require 
surgical intervention. The intraoperative environment includes several risk factors for non-
euglycemic events, such as the premature neonate’s immature hormonal response, surgical stress 
response, and metabolic effects of anesthetics and analgesics (Agus & Jaksic, 2002; Heimann, et 
al., 2007; McEwan, 2009). Despite the combination of a high-risk population and a high-risk 
environment, anesthesia providers do not consistently monitor or manage blood glucose levels in 
premature neonates during the intraoperative period (Ayers & Graves, 2001). There is a need to 
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determine both the prevalence of, and risk factors for, intraoperative non-euglycemic events 
(IONEE) in preterm neonates to direct the development of clinical practice guidelines. 
Maintaining Euglycemia is Essential in Premature Neonates because Non-Euglycemic Events are 
Associated with Adverse Health Outcomes 
Compared to adults, neonates have higher per body weight energy requirements, 
decreased energy stores, and a decreased tolerance for noneuglycemic events (McHoney, Eaton, 
& Pierro, 2009; Pierro & Eaton, 2008). In fact, euglycemia is considered an essential clinical 
goal in neonatal resuscitation curricula such as NRP and STABLE (AHA, 2006; International 
Liaison Committee on Resuscitation (ILCOR), 2006: Karlsen, 2006; Zaichkin, 2006)  Premature 
neonates experiencing recurrent or persistent noneuglycemic events have significantly more 
adverse health outcomes than those with euglycemia. Hyperglycemia events in premature 
neonates are associated with an increased risk for intraventricular hemorrhage, osmotic diuresis, 
dehydration, retinopathy of prematurity, early death, sepsis and further release of insulin to 
rebound hypoglycemia events (Blanco, et al., 2006; Garg, et al., 2003; Heimann, et al., 2007; 
Kao, et al., 2006; Sharma, et al., 2009). Hypoglycemic events in premature neonates increase the 
risk for events seizures, and short and long-term neurodevelopment and physical growth deficits 
in preterm neonates (Basu, Som, Choudhuri, & Das, 2009; Boluyt, van Kempen, & Offringa, 
2006; Mao, Chen, Fu, Li, & Xue, 2007; Memon & MM, 2006; Narayan, Aggarwal, Deorari, & 
Paul, 2001; Sankar, Agarwal, Aggarwal, Deorari, & Paul, 2008; Tam, et al., 2008) 
Euglycemia is More Difficult to Achieve and Maintain in Premature Neonates  
Although maintaining euglycemia in the neonate population is difficult, it is particularly 
challenging in preterm neonates whose weight is < 2500 grams. Preterm neonates have 
  
 3 
significantly higher resting energy expenditures (110-160 kcal/kg/day) than full-term neonates 
(100-120 kcal/kg/day) (Pierro & Eaton, 2008). Hypoglycemic events are commonly reported in 
preterm neonates, more commonly among newborns and those classified as low birth weight 
(McHoney, et al., 2009; Van Kempen, 2005). In addition, premature neonates may have a 
decreased response to insulin and when dextrose infusions are administered, these neonates may 
experience hyperglycemia events.  Preterm neonates are at higher risk of developing 
noneuglycemic events due to many factors including decreased glycogen stores, immature 
insulin response, and increased metabolic demands (Mericq, 2006; Motoyama & Davis, 2009; 
Simmons, 2007). In fact, a direct correlation between birth weight and glycogen stores has been 
reported (Mitanchez, 2007; Pierro & Eaton, 2008; Van Kempen, 2005).  
Euglycemia is More Difficult to Maintain in Preterm Neonates Undergoing Surgery due to 
Metabolic Responses to Surgical Stress, Anesthetic Agents, and Analgesic Medications 
Although not common place, some preterm neonates require surgical interventions such 
as those with patent ductus arteriousus repair, omphalocele, and gastroschisis. Tissue damage 
and pain associated with surgical procedures trigger a stress response involving endocrine, 
inflammatory, and metabolic components with local and systemic consequences. Of particular 
note is the rapidness of the metabolic elevation seen in the neonate population. For instance, 
neonates undergoing abdominal surgery had a peak increase in resting energy requirements 
within 4 hours (Pierro & Eaton, 2008). The increased demand may even be more pronounced if 
the neonate has severe underlying illness – which frequently necessitates the surgical procedure. 
Premature neonates of 26-32 weeks of gestational age or older have an integrated nociceptive 
system resulting in an effective metabolic and hormonal response to catecholamines (McEwan, 
2009; Pierro & Eaton, 2008). Surgical stress responses, including noneuglycemic events, have 
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been associated with premature neonatal mortality and morbidity (Agus & Jaksic, 2002; 
Heimann, et al., 2007; McEwan, 2009). Severity of the stress response is directly proportional to 
the magnitude of the operative intervention (Jones, Pierro, Hammond, & Lloyd, 1993). 
Furthermore, preoperative fasting further increases the premature neonate operative stress 
response (McHoney, Eaton, & Pierro, 2009). However, not every intraoperative event has an 
adverse impact on metabolism. Anesthetic agents (both general and local/regional) as well as 
analgesic medications have reportedly reduced some metabolic responses (McHoney, et al., 
2009). The preterm neonate in the intraoperative environment combines a high risk population 
with a high risk situation with regards to development of noneuglycemic events.  
Problem 
Intraoperative Neonatal Euglycemia is not Routinely Monitored 
Premature neonates receiving preoperative total parenteral infusions receive dextrose 
infusion during the intraoperative period. Surgical stimuli and drugs administered during the 
intraoperative can further alter blood glucose levels. Clinical guidelines for monitoring and 
maintaining euglycemia in premature neonates have been established for the preoperative and 
postoperative periods. Therefore, the establishment of intraoperative glycemic control guideline 
for the monitoring and maintenance of euglycemia in premature neonates in order to avoid the 
occurrence of non-euglycemic events is imperative. 
Significance/Importance of Problem to Nursing Practice 
The contribution of the proposed research is expected to be empirical evidence regarding 
the magnitude and risk factors for INOEE to support the development of clinical guidelines to 
maintain intraoperative euglycemia in the preterm neonate population. This contribution will be 
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significant because anesthesia providers currently do not consistently monitor or manage blood 
glucose levels in premature neonates despite the intraoperative period being a combination of 
high risk patients and conditions. Results of this study will advance knowledge regarding both 
the prevalence and risk factors for IONEE. Furthermore, they will provide empirical evidence to 
support future research toward preventing IONEE in other populations as well. 
Goals of the Project 
Develop Neonatal Intraoperative Clinical Guidelines for Monitoring and Treating Non-
Euglycemic Events 
The long-term goal is to improve health outcomes for premature neonates experiencing a 
surgical procedure by developing intraoperative clinical guidelines for monitoring and treating 
IONEE. 
Determine Neonatal Intraoperative Non-Euglycemic Events Prevalence Rate and Risks Factors 
The overall objective of this project, which is the first step in achieving this long-term 
goal, is to determine both the prevalence of and risk factors for IONEE in preterm neonates. The 
rationale underlying the proposed research is that actions maintaining intraoperative euglycemia 
decrease the risk for adverse health outcomes in this vulnerable group. For purposes of this 
study, a premature neonate is defined as those neonates whose gestational age at birth is < 37 
weeks.  
Project Question  
 What is the prevalence and risk factors of intraoperative non-euglycemic events in 
premature neonates less than 2,500 grams? 
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Specific Aims  
Aim 1: Identify the prevalence of intraoperative non-euglycemic events in premature 
neonates < 2,500 grams. 
Aim 2: Determine the association between intraoperative non-euglycemic events and 
specific operative characteristics. 
Aim 3: Determine the association between intraoperative non-euglycemic events and 
preterm neonatal physiological characteristics.  
Aim 4: Determine association between intraoperative non-euglycemic events and specific 
anesthesia provider resuscitation measures. 
Summary 
Neonates who require surgery are at a high risk for non-euglycemic events.  Data are 
needed to support development of clinical practice guidelines for the anesthesia providers.   
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CHAPTER 2: METABOLIC RESPONSE TO SURGERY AND ANESTHESIA DRUGS 
IN PREMATURE NEONATES 
Premature Neonatal Metabolism and Nutritional Support 
  Achieving glucose homeostasis in premature neonates during the perioperative period 
may be difficult due to factors including higher metabolic and energy requirements, preexisting 
illnesses, preoperative treatments, intensity of surgical stimuli, and ability of anesthesia drugs to 
blunt these stimuli. Neonates have a higher metabolic rate and energy requirement than adults. 
The neonatal population energy requirements are 120-140 kcal/kg/day of which 40-70 
kcal/kg/day are needed for  metabolism, 50-70 kcal/kg/day are needed for growth, and 20 
kcal/kg/day are needed for energy losses in excreta (Jaksic & Shew, 2004; Pierro & Eaton, 
2006). Energy expenditure may vary according to neonate activity level. When neonates cry or 
move, their energy expenditure may double. On the other hand, during surgery, infants are at rest 
80-90% of the time. The maturity level of neonates determines resting energy expenditure (REE) 
in surgical situations. Full term neonates require 100-120 kcal/kg/day during surgery, while 
premature surgical neonates require 110-160 kcal/kg/day (Pierro & Eaton, 2008). The REE 
differences among these types of neonates may explain differences in their growth rates.  
 Surgical stress from major abdominal surgery affects the postoperative metabolic 
response of neonates. Neonates respond to surgical stress after major abdominal surgery with an 
immediate elevation of oxygen consumption and resting energy expenditure that returns to 
normal rate between 12-24 hours during the postoperative period (Pierro & Eaton, 2006). 
Additionally, it has been speculated that neonates utilize energy and protein from growth rate for 
tissue repair. Early growth deficits may cause long-term adverse effects such as poor 
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neurodevelopmental outcomes (Yu, 2005). Therefore, neonates may require parenteral and other 
special nutritional supports to overcome growth restrictions caused by the surgical experience.  
 Parenteral nutrition (PN) is commonly used for neonates who require surgery to support 
metabolic needs related to surgical procedures, critical illness, and/or sepsis. When enteral 
feeding for more than 4-5 days is inadequate, parenteral nutrition is indicated. Parenteral 
nutrition includes carbohydrates, fat, protein, vitamins, trace elements, and water (Pierro & 
Eaton, 2008). Carbohydrates and fat are necessary sources of calories to avoid protein oxidation 
for energy. Glucose supply must be initiated at 6mg/kg/min and may be increased daily up to 12 
mg/kg/min in order to maintain glucose levels above 45 mg/dL. Additionally, studies have found 
that the administration of glucose must not exceed 18g/kg/day in surgical neonates to avoid 
excessive production of CO2
The supplementation of intravenous essential fatty acids is essential in premature 
neonates due to their inability to acquire fatty acids from dietary sources. Additionally, the 
limited adipose tissue in premature neonates makes them vulnerable for this deficiency. 
Therefore, to prevent essential fatty acid deficiency in premature neonates, 0.25 to 0.5 g/kg/day 
of essential fatty acids is recommended for intravenous administration. Simmer and Rao (2009) 
 and plasma triglycerides (Pierro, 2002). The quantity of glucose 
administered determines how much fat or carbohydrates are utilized. In neonates with surgical 
procedures, only 18/g/kg/day may be oxidized to comply with their energy expenditure. When 
excessive quantities of glucose are administered in this population, the oxidative capacity is 
reached resulting in a number of metabolic changes, including cessation of fat oxidation, 
increased fat synthesis, decreased glucose metabolism, increased carbon dioxide production and 
increased triglyceride levels (Pierro & Eaton, 2008). Therefore, carbohydrate intake must remain 
below energy requirements to avoid fat accretion (Hulzebos & Sauer, 2007; Pierro, 2002).  
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reviewed five randomized clinical trials and concluded that there was not a significant difference 
between administering ‘early’ versus ‘no early’ lipids to premature neonates who developed 
complications such as bronchopulmonary dysplasia and retinopathy of prematurity. The time 
difference between ‘early’ and ‘no early’ is only five days. Theoretically, the early 
administration of lipid emulsions could decrease the prevalence of complications associated with 
free radical formation, such as bronchopulmonary dysplasia (BPD) and retinopathy of 
prematurity (ROP) (Simmer & Rao, 2009). This hypothesis was not accepted in the clinical trials 
reviewed, perhaps because of the preexisting morbidities that contribute to the formation of BPD 
and ROP in premature neonates. 
The supply of intravenous protein to premature neonates should provide enough amino 
acids to support tissue growth. The more immature or small the neonate, the higher the need for 
protein and energy to support the rapid growth rate (Valentine & Puthoff, 2007). Term neonates 
require approximately 110 to 120 kcal/kg/day of energy for an adequate growth rate. On the 
other hand, low-birth-weight (<1500g) neonates may need up to 150 kcal/kg/day of energy to 
achieve an adequate growth rate (Chwals, 2003). Neonatal protein requirements are between 2.5 
to 3.0 g/kg/day but premature infants may require up to 4g/kg/day to maintain stores and support 
growth (Parish & Bhatia, 2008; Pierro & Eaton, 2008; Valentine & Puthoff, 2007). 
Since surgical premature neonates experience elevation of oxygen consumption and 
resting energy requirements (REE), the risk of non-euglycemic events may increase. Therefore, 
it is essential that these surgical neonates receive an adequate nutritional support such as no more 
than 18 g/kg/day of glucose, essential fatty acids and up to 4g/kg/day of protein to support their 
tissue repair process and growth rate. 
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Other factors such as preexisting pathophysiological conditions and treatment modalities 
may contribute to the nutritional challenges found in neonates undergoing surgical procedures. 
For example, preexisting critical illness, sepsis, prematurity, respiratory distress, mechanical 
ventilation, chronic lung disease, and thermal environment have been identified as factors that 
may increase energy expenditures in surgical neonates (Hulzebos & Sauer, 2007). Possible 
therapeutic measures to restore the damages of metabolic response to sepsis in neonates are 
under study. Eaton (2003) discussed how the administration of glutamine in septic neonates 
could restore their mitochondrial structure and metabolism. When neonates acquire a bacterial 
infection, pro-inflammatory cytokines (the antimicrobial activity of macrophages and 
neutrophils), H2O2
Metabolic Response to Surgery 
, Nitric Oxide, superoxide, and peroxynitrite are produced (Eaton, 2003). 
These reactive products are responsible for the impairment of mitochondrial oxidative function 
causing hypothermia and hypometabolism in neonates.  
Surgical Procedures in the Neonatal Population May Alter Physiological Conditions  
All neonates with a viable 26-32 weeks of gestational age have nociceptive systems that 
are integrated with brainstem cardiovascular control centers (Kinouchi, 2004; McEwan, 2009). 
These cardiovascular control centers are capable of triggering humoral and circulatory responses 
to pain and stress. Hormonal stress responses in surgical neonates are three-fold to five-fold 
greater than adult responses in similar surgical procedures (McEwan, 2009). Increases of 
circulating catecholamines, glucagon, cortisol, beta endorphins, growth hormone, and insulin 
have been identified as surgical stress responses that might last for several days (24-72 hours) 
postoperatively. It has been suggested that these surgical stress metabolic responses may be 
  
 11 
associated with mortality and morbidity during the postoperative period. The metabolic 
responses to surgical stress in neonates include increases in oxygen consumption, 
glycogenolysis, gluconeogenesis, and lipolysis (Agus & Jaksic, 2002; McEwan, 2009). In 
addition, these metabolic responses cause substantial intraoperative and postoperative 
catabolism. The metabolic responses to surgical stress are the result of changes in plasma 
cortisol, catecholamines, and regulatory hormones such as growth hormone and glucagon. Net 
results from these metabolic responses are perioperative hypoglycemia and hyperglycemia, lactic 
acidemia, and postoperative negative nitrogen balance (McEwan, 2009). Factors such as fast 
growth rate; limited endogenous reserves of carbohydrates, proteins and fats; high glucose 
requirements for a relative large brain; immature hormonal control of intermediary metabolism; 
and immature enzymes systems in the metabolic organs, contribute to an impaired tolerance to 
surgical stress (McEwan, 2009; Owens & Musa, 2009).  
Heiman, Peschgens,  Kwiecien, Stanzel, Hoernchen and Merz (2007) studied how 
recurrent hyperglycemia episodes during the first week of life in premature infants ≤ 1500 grams 
affected the morbidity and mortality of these neonates. In this study, neonates less than 27 weeks 
of gestational age with repeated episodes of hyperglycemia (more than 4 times) greater than 150 
mg/dL, had a significant increase in mortality. The authors also found that the incidence of 
intraventricular hemorrhage and sepsis in the premature neonates was higher; and therefore, 
these two factors perhaps contributed to their mortality rate. Glucose aberration could have been 
secondary to these other large insults. 
Chwals, Letton, Jamie and Charles (1995) studied how preexisting illness in neonates and 
infants up to 47 days old predicted their increased hypermetabolic response after a surgical 
procedure. C-reactive protein concentration greater than 6.5 mg/dL in plasma was present in 
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infants with preoperative sepsis or major inflammatory processes, indicating an increase in 
energy expenditure (hypermetabolism). The measured energy expenditure (MEE) was elevated 
during the postoperative period in those infants with elevated C-reactive plasma protein. The 
authors concluded that by measuring the postoperative MEE in sick surgical neonates and 
infants, clinicians could measure the severity of injury in neonates and support their nutritional 
needs (Chwals, 1995). This study contributed to the understanding of when to expect 
hypermetabolism in surgical neonates.  
Powis, Smith, Rennie, Halliday and Pierro (1998) studied whether major abdominal 
surgeries affected the energy and protein metabolism in infants and children (2 days to 3 years 
old). Surgery durations were between 28 to 285 minutes and the mean operative stress scores 
was 8. The anesthesia was standardized in the study. Whole body protein flux, protein synthesis, 
amino acid oxidation, and protein degradation were measured for four hours preoperatively and 
six hours after surgery. The authors found that infants and children did not increase their whole 
body protein turnover and metabolic rate after major abdominal surgery. They concluded that 
infants and children diverted protein synthesis from growth to tissue repair. This study points out 
the importance of nutritional support for surgical neonates. More research studies are needed 
particularly on premature neonates since this population has a greater growth rate and may have 
increased nutritional needs to support growth during perioperative periods. 
In 2008, Reynolds, Bass and Thureen studied if neonates undergoing abdominal surgery 
on their first day of life were able to achieve a positive balance of protein with the administration 
of parenteral amino acids. The neonates were full term and had appropriate weight for their 
gestational age. The authors concluded that these neonates tolerated nutritional support with 
amino acids; however, the study classified them as “ill” without defining their illness. Also, part 
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of the exclusion criteria was the presence of sepsis and congenital or metabolic abnormalities. 
Administration of analgesia during the anesthesia management may also have contributed to the 
final positive protein balance found immediately after surgery. It would be relevant to repeat this 
study on premature neonates since this population has a higher incidence of illness, surgical 
procedures, and metabolic needs. 
Research evidence shows that premature neonates experience metabolic responses to 
surgical experience. Increases in their oxygen consumption, gluconeogenesis, glycogenolysis and 
lipolysis may occur as metabolic responses to surgery. However, preexisting diseases such as 
sepsis may lead to hypometabolism. The degree of metabolic response to surgical stimuli in 
premature neonates is unknown. This lack of knowledge affects the ability to support the surgical 
neonates’ nutritional needs leaving them vulnerable for a growth and neurodevelopmental 
deficit. Finding the relationship between intraoperative non-euglycemic events and type and 
length of surgery and preexisting diseases, could guide us to support their nutritional needs for 
tissue repair and normal growth.  
Metabolic Response to Anesthesia Drugs 
 During anesthesia management, opioids are used to blunt pain caused by surgical 
stimuli. Different anesthesia techniques are implemented to decrease the hormonal and metabolic 
responses to surgical stimuli. Anand, Phil and Hickey (1992) compared two different anesthetics 
to hormonal and metabolic response: the use of Halothane (volatile agent) and morphine (opioid) 
versus the use of high dose of sufentanil. The anesthesia technique that included sufentanil was 
deeper and significantly reduced hormonal and metabolic responses. The surgical procedures in 
this study included five different cardiac surgeries which could have variations in the intensity of 
  
 14 
surgical stimuli (Anand & Hickey, 1992). Additionally, the neonates that participated in this 
study were full term therefore their capacity for metabolic response to surgical stimuli could 
have differed from premature neonates. 
Bouwmeester, Anand, van Dijik, Hop, Boomsma and Tibboel (2001) studied the 
hormonal and metabolic responses of children between the ages of 0-3 years old who were 
undergoing twenty-two different thoracic and abdominal surgical procedures. Morphine was 
administered intermittently and continuously during the postoperative period. The authors found 
that the neonates had higher preoperative levels of norepinephrine and lactate, while their 
postoperative plasma epinephrine levels were significantly lower than in the older children 
group. Additionally, the neonates needed less amounts of opioids during their postoperative 
period than the older children. No significant differences were found between the effectiveness 
of continuous versus intermittent administration of morphine in the study groups. The authors 
concluded that the immaturity of organs for drug clearance in neonates decreased the need for 
opioid administration during the postoperative period. Additionally, the elevated epinephrine 
levels in children during the postoperative period could be explained as being related to the 
higher levels of anxiety that the subjects experienced during the study. In this study, the neonates 
were full term which could have assisted the metabolic adaptation response to stress. 
Additionally, the neonate group underwent more gastrointestinal surgeries, which may have 
altered the intensity of surgical stress in comparison with the children group. 
Gruber, et al. (2001) studied the stress response of infants younger than six months 
undergoing cardiac surgery. Three different techniques of Fentanyl administration were used: 
fentanyl bolus, fentanyl infusion, and the combination of fentanyl-midazolam infusion. 
Metabolic responses were measured during five different times: after sternotomy, 15 minutes 
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after initiating cardiopulmonary bypass, at the end of surgery, and 24 hours after surgery in the 
intensive care unit. The authors concluded that none of the fentanyl dosing strategies, with or 
without midazolam, would prevent a hormonal or metabolic response in infants undergoing 
cardiac surgery. Subjects in the study underwent four different cardiac surgeries which could 
have caused variation in surgical procedure duration and intensity of surgical stimuli. 
Additionally, the number of subjects per surgical procedure group or fentanyl administration 
technique was unequal therefore the study conclusions may not be reliable due to analysis 
inconsistencies. Within each group of infants receiving fentanyl bolus, fentanyl infusion, and the 
combination of fentanyl-midazolam infusion; epinephrine, norepinephrine, cortisol, glucose and 
lactate levels were significantly larger at the end of surgery.  
Kussman, Gruber, Zurakowski, Hansen, Sullivan, and Laussen (2001) studied the 
relationship of Bispectral Index (BIS) data to stress response and plasma fentanyl levels in 
nineteen infants less than six months old who underwent cardiac surgery. Four types of cardiac 
surgery were chose for this study: complete atrioventricular canal, tetralogy of Fallot, ventricular 
septal defect, and hemitruncus arteriosus. The BIS has been recommended as a monitor of 
consciousness level in anesthesia, but use of this monitor has not been validated in pediatric 
patients. These authors looked for a correlation between hemodynamic (changes in heart rate and 
blood pressure) and neuroendocrine responses (epinephrine, norepinephrine, cortisol, ACTH, 
glucose, and lactate) with changes in BIS data. Three opioid administration techniques were 
used: fentanyl bolus, fentanyl infusion, and fentanyl-midazolam infusion. Metabolic and 
hormonal responses were measured during four intraoperative times: 15 minutes postinduction, 
15 minutes poststernotomy, 15 minutes on cardiopulmonary bypass during cooling, and at the 
completion of surgery. The authors concluded that there was no correlation between the changes 
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in hormonal or metabolic responses and the changes in the BIS. They did find a correlation 
between hypothermic events, hypoperfusion, and changes in the BIS. Given that the use of BIS 
in neonates has not been validated, the efficacy of this device to monitor deepness of anesthesia 
in preterm infants is even more questionable. Changes in hormonal and metabolic responses in 
the preterm population may be more reliable in identifying increases in metabolic and hormonal 
responses caused by changes in the intensity of surgical stimuli. 
Other opioid anesthetic techniques have been studied in relationship to pain control and 
surgical stress. Bell, Dickson, Arana, Robinson, Marshall, and Morton (2004) compared the 
effects of remifentanil and fentanyl on surgical stress in pediatric patients (4-108 months old) 
undergoing cardiac surgery. Glucose and cortisol levels were measured periodically from the 
period before induction into the postoperative intensive care period. The seven cardiac surgeries 
performed in this study were similar; however, the anesthesia induction drugs used for subjects 
were different. For example, three of the 17 pediatric patients received ketamine as an inductive 
drug. Ketamine causes catecholamine release and analgesia; therefore, the use of this drug with 
opioids may have altered metabolic and hormonal responses to the cardiac procedures. The 
authors concluded that there was no clinically significant difference between the two opioid 
techniques in decreasing hormonal and metabolic responses to cardiac surgery stimuli. 
Additionally, the subjects in the study were four or more months old which make generalization 
of results to premature infants problematic. 
Remifentanyl has been the opioid of choice to blunt pain in pediatric patients due to its 
unique rapid titratable effect. Weale, Rogers, Cooper, Nolan, and Wolf (2004) studied the 
metabolic responses to surgical stimuli in infants and children undergoing cardiac surgery after 
the administration of four different Remifentanil infusion rates (0.25, 1.0. 2.5, or 5.0 ug/kg/min). 
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Cortisol, neuropeptide Y, and glucose were measured at induction, pre-surgery, 5 minutes after 
opening the heart, and immediately before going on cardiopulmonary bypass. The authors 
reached two conclusions: remifentanil infusion rates greater than 1.0 ug/kg/min can suppress 
increases in blood glucose and tachycardia during the pre-bypass phase, and neonates with 
complex cardiac conditions (transpositions of the great arteries) may develop severe bradycardia. 
In this study, the specific ages of subjects were not given therefore it is unknown if preterm 
neonates participated. Additionally, seven different cardiac surgeries were performed on study 
subjects and could have affected the degree of surgical stimuli experienced. 
Mechanical ventilation may also increase energy demands in the neonatal population 
during their intraoperative period. Neonatal intensive care unit providers have studied the effects 
of morphine on plasma adrenaline and norepinephrine concentration levels. Simons, et al. (2005) 
evaluated the effects of morphine on neonates with mechanical ventilation. Study neonates were 
between 27.5 to 32.1 weeks of gestational age. The authors concluded that morphine infusion 
may suppress metabolic stress caused by mechanical ventilation. However, one third of the 
group receiving morphine infusion also received dopamine infusion, which may also have had 
some effect on the metabolic responses during mechanical ventilation. Therefore, the effects of 
morphine infusion on these neonates could have been greater that what the authors actually 
found. This study contributes to anesthesia provider knowledge since mechanical ventilation is 
needed for respiratory support during neonatal surgical procedures requiring general anesthesia. 
Another anesthesia technique used to blunt metabolic responses in surgical patients is the 
administration of epidural anesthesia. Schricker, Meterissian, Wykes, Eberhart, Lattermann, and 
Carli (2004) measured metabolic responses to major abdominal surgeries in adult patients. 
Postoperative amino acids were measured with a leucine stable isotope tracer technique 
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(Schricker, et al., 2004). Additionally, the researchers administered a hypocaloric Dextrose10% 
infusion for 24 hours from the day before surgery until the second day after surgery. The authors 
concluded that the administration of epidural anesthesia (bupivacaine and fentanyl) with a 
hypocaloric dextrose infusion blunted amino acid oxidation saving more than 100 grams of lean 
body mass. More research studies are needed to evaluate regional anesthesia and hypocaloric 
combined treatment in the neonatal population. Neonates who are premature may benefit from 
saving amino acids not only for wound healing but also for growth rate needs. Perhaps the 
epidural anesthesia approach should be substituted with a caudal block (McEwan, 2009). 
Another anesthesia technique that preserves total body protein after a major upper 
gastrointestinal surgical procedure is the administration of an epidural (opioid and local 
anesthetic) combined with an intravenous anti-inflammatory drug for 48 hours and intravenous 
lipid-based nutrition (Barratt, Smith, Kee, Mather, & Cousins, 2002). This study examined the 
administration of patient-controlled opioid analgesia (PCA) along with intravenous lipid-based 
nutrition. The subjects in this study were adults (49 to 68 years of age). They found that the 
combination of multimodal analgesia (epidural anesthesia and intravenous anti-inflammatory 
drugs) and the administration of lipid-based intravenous nutrition significantly reduced pain and 
preserved total body protein and fat. More research on how to blunt metabolic responses to 
surgical stimuli with the use of regional anesthesia (caudal block) combined with administration 
of parenteral nutrition to avoid catabolism is needed on the neonatal population. 
Crozier, et al. (1993) conducted a study to measure the immediate postpartum condition 
of neonates delivered by the anesthetic induction drug used for cesarean section where an 
anesthesia induction agent was used. They compared the metabolic effects on full term neonates 
whose mothers received either etomidate or methohexitone for general anesthesia induction for 
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cesarean section. Plasma cortisol and blood glucose levels were measured before induction, after 
umbilical clamping, 2 hours postpartum, and 6 hours postpartum. Neonates delivered via 
emergency caesarean section who suffered intrauterine distress and whose mothers received 
etomidate for general anesthesia induction had a temporary decrease in plasma cortisol and 
glucose levels. More studies are needed to evaluate the effects of etomidate on premature 
neonate metabolic responses to this drug. 
Minor surgeries such as tympanoplasty and skin graft are usually managed without 
opioids and only use Sevoflurane and nitrous oxide to blunt metabolic responses to surgical 
stimuli. Terajima and Ogawa (2000) studied the effect of glucose infusion administration on 
usage of energy sources during these two minor surgeries. The adult patients in their study 
received three different glucose 20% infusion rates, 0.1, 0.2, 0.3 g/kg/h. The authors concluded 
that low glucose infusion rate (0.1 g/kg/h) was needed to prevent hyperglycemia and lipolysis 
events in adults undergoing tympanoplasty and skin graft without opioid administration and only 
use of Sevoflurane for general anesthesia. More research is needed on general anesthesia 
administration without opioids in neonates undergoing minor surgery. Since adults and neonates 
differ in metabolic needs, perhaps the requirements for glucose infusion to maintain adequate 
usage of energy resources during minor surgeries would be higher in neonates. 
In summary, anesthesia care providers are responsible for preparing and supporting 
preterm neonates during their perioperative period. Today, this mission is harder to accomplish 
since the viability of premature neonates at 23-26 weeks of gestational age has increased. The 
neonate immaturity, decreased energy storage, and higher metabolic demands for growth make it 
challenging for care providers to respond to their unique needs during surgical procedures. More 
research studies are needed to determine the effects of surgical procedures and anesthesia drugs 
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on premature neonatal metabolic responses. The identification of metabolic responses to specific 
surgical procedures in premature neonates may facilitate the planning of nutritional support 
during their perioperative period. Additionally, the identification of anesthesia drugs, neonatal 
physiological characteristics, and anesthesia provider resuscitation measures effects on neonatal 
metabolic responses also would facilitate the designing of an adequate clinical guideline that 
would support euglycemic events during their perioperative period.  
Definition of Hypoglycemia for Premature Neonates 
Limited evidence and no consensus were found for the definition of hypoglycemia in 
premature neonates. Some authors have studied the effects of moderate to severe hypoglycemia 
events on immature brains of premature neonates that experienced brain injury.. Some of the 
effects of hypoglycemia on immature brains identified are cortical atrophy, white matter T2 
prolongation in the occipital area of the brain, periventricular leucomalasia in the occipital area 
of the brain, and diffuse white matter volume loss in the parietal area of the brain (Montassir, et 
al., 2009; Tam, et al., 2008). Hypoglycemia in these neonates who experienced brain injury was 
defined as premature and full term neonates (>37 weeks of gestation) who had whole blood 
glucose  concentration below 35 mg/dl 0-3 hours after birth, 40 mg/dl 3-24 hours after birth, and 
45 mg/dl after 24 hours of birth time. Other authors guide themselves to treat hypoglycemia in 
premature neonates according to the existence of symptoms of seizures and irritability and 
expect their blood glucose levels to be < 36 mg/dl during the first 24 hours of life (Hernandez, 
2006; Milcic, 2008). In addition, Milcic in 2008 explained that the hypoglycemia definition in 
premature neonates cannot be defined with a single value because of the different causes that 
might be present. Some of these causes could be a diminished hepatic glucose production or 
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excessive insulin productions which are possible pathologies of premature neonates or simply the 
result of these neonates immaturity level (Milcic, 2008).  Some neonatal intensive care units 
have defined hypoglycemia in premature neonates whose blood glucose level is < 40 mg/dl if 
they are small for gestational age and may be experiencing illness such as necrotizing 
enterocolitis and sepsis (Adamkin, 2009). 
 Considering that neonatal surgical procedures in premature neonates are for the most part 
due to illness and those premature neonates less than 2,500 grams include different levels of 
maturity, in this retrospective study hypoglycemia is defined as a blood glucose level <40 
mg/dL. 
Definition of Hyperglycemia 
Hyperglycemia in premature neonates has also not been clearly defined. Hyperglycemia 
in premature neonates has been defined as whole blood glucose level > 150 mg/dl. The range 
value for hyperglycemia in premature neonates (> 150 mg/dL) compared to full term neonates (> 
125 mg/dL) is higher due to  the higher nutritional demands that premature neonates have (Hey, 
2005; Kairamkonda & Khashu, 2008; Sinclair, Bottino, & Cowett, 2009). However, blood 
glucose levels >216 mg/dl have been used as operational definition of hyperglycemia in 
premature neonates as a cut off to assess for the presence of osmotic diuresis. On the other hand, 
there is evidence that suggests that a blood glucose level > 360 mg/dL is required to cause 
significant osmotic diuresis in this neonatal population (Kairamkonda & Khashu, 2008). Since 
premature neonates are unable to inhibit gluconeogenesis when intravenous glucose infusions are 
administered (Hume, Burchell, Williams, & Koh, 2005), and evidence has suggested that sick 
premature neonates have showed a delayed or decreased secretion of insulin as a response to 
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excessive glucose concentrations in blood (Mena, Llanos, & Uauy, 2001), hyperglycemia in this 
retrospective study is defined as a blood glucose level > 150 mg/dL. 
Definition of Euglycemia in Premature Neonates 
For the purpose of this research study, euglycemia in surgical premature neonates is 
defined as a blood glucose level within the range of 40 to 150 mg/dL. 
Accuracy of Glycemic Measurements with Point of Care Testing Devices 
One of challenges that health care providers who care for neonates encounter when 
monitoring blood glucose levels is that blood volume in premature neonates must be preserved 
because of their small body size. Obtaining just 1 mL of blood from premature neonates younger 
than 28 weeks of gestational age with a weight <500 grams can account for almost 2.5% of their 
total blood volume. When blood glucose levels and arterial gases are tested several times a day 
these premature neonates risk blood volume depletion. For this reason, point-of-care testing 
(POTC) devices such as the glucometer are used to decrease the amount of blood needed for 
blood glucose testing. 
Several research studies have addressed factors that must be considered when POCT 
devices are used. Some of these factors are: human error, differences in blood glucose values 
among sites of blood collection (arterial versus capillary blood samples), hematocrit levels, 
presence of maltose in blood sample, accuracy of POCT glucometers, and the relationship 
between the level of patient acuity and the accuracy of blood sample site. Kavsak, Zielinski, Li, 
Namara, and Adeli (2004) examined the factors that contributed to analytical bias in POCT 
glucose values obtained in a Neonatal Intensive Care Unit versus the central laboratory. They 
concluded that differences in the amount of blood volume applied to glucometer strips affected 
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the POCT glucose values by increasing values up to 15% above the central laboratory results. 
Boyd, Leigh, and Stuart (2005) examined differences between capillary and venous blood 
glucose values taken at the bedside in emergency department patients in comparison with central 
laboratory glucose values (Dade-Behring Multichannel Analyzer). They concluded that venous 
samples could be accurately tested in capillary glucometers (Medisense Precision Plus). 
However, when extreme values were obtained using this POCT, the authors recommended that 
blood glucose must be re-tested at the central laboratory (Boyd et al., 2005). Karon, et al. (2007) 
compared blood glucose values using POCT for capillary, arterial and venous whole blood, and 
central laboratory blood glucose testing. The POCT device was the Accucheck Inform. The 
authors found no significance difference between the POCT capillary blood glucose values and 
the central laboratory blood glucose values (Double P Modular Sytem: hexokinase method). 
However, the arterial and venous whole blood glucose values were significantly higher than the 
central laboratory blood glucose values. 
Abnormal hematocrit levels have been identified as an important factor when obtaining 
POCT glucose values. Ghys, Goedhuys, Spincemaille, Gorus and Gerlo (2007) tested the 
accuracy of the Precision PCX and Accucheck Inform POCT devices in diabetic patients 
between 17 to 95 years of age. The blood glucose values for venous and capillary samples were 
measured with both POCT devices in individuals who had normal, abnormal high, and abnormal 
low hematocrit values. In addition, individuals who received maltose solutions for peritoneal 
dialysis were also tested with these devices. Glucose levels were overestimated in patients 
receiving maltose solutions when tested with the Accucheck Inform. In addition, when 
hematocrit levels were elevated, blood glucose measurements were underestimated with both 
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POCT devices. When hematocrit levels were abnormally low, the Precision PCX showed an 
overestimated blood glucose value (Ghys et al., 2007). 
Critically ill patients may have inadequate peripheral perfusion which could alter the 
quality of, or access to, capillary blood samples. Salter-Maclean et al. (2008) compared 
differences in blood glucose values of whole blood capillary and arterial samples measured with 
three different glucometers (SuperStepFlexx, Accu-check Inform, and FreeStyle) and one blood 
gas analyzer (Chiron 865). All samples were compared with central laboratory values (Yellow 
Springs Instrument). The authors found that capillary blood glucose values were higher than 
arterial values measured at the same time. Therefore, the authors recommended that arterial 
blood samples should be used in critically ill patients using the FreeStyle or Chiron 865 POCT 
devices to obtain more accurate blood glucose values. Kanji et al. (2005) also examined the 
accuracy of three POCT devices for blood glucose measurement using a sample of critically ill 
patients on insulin infusion. The sites for blood collection for this study were capillary and 
arterial. Blood glucose levels were measured with the Accucheck Inform (glucometer), Rapid lab 
860 (blood gas analyzer), and LX20 analyzer (central laboratory oxidase/catalase method). The 
authors concluded that all POCT devices were inadequate measurement tools during 
hypoglycemic events. Arterial blood gas testing demonstrated the most reliable blood glucose 
level results and was recommended by the authors as the safer method to use during 
hypoglycemic events  
Meynaar, et al. (2009) suggested that blood glucose levels in whole blood are 15% lower 
than in plasma. The International Federation of Clinical Chemistry and Laboratory Medicine 
Scientific Division established a conversion factor between plasma and whole blood glucose 
values of 1.11 (D’Orazio et al., 2006). This factor was established under normal values of 
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hematocrit since a decreased hematocrit increases whole blood glucose values. In order to ensure 
that whole blood glucose measurements and plasma glucose measurements are compatible, 
POCT devices are calibrated to correct for differences in blood glucose values (Karon et al., 
2007).  
In summary, when whole blood glucose values are measured with POCT devices, several 
factors such as hematocrit levels, present morbidities, site of blood collection, accuracy of the 
POCT device, presence of maltose in blood, and human error may alter the blood glucose values 
obtained. Until more research studies identify how these factors can be controlled when blood 
glucose levels are measured in premature neonates, extreme low or high blood glucose values 
must be confirmed with central laboratory testing before treatment is implemented. 
The AccuCheck Inform POTC has been used at the study facility to measure capillary 
and arterial blood glucose levels. The AccuCheck Inform has been calibrated with a reagent strip 
and a specific chip inserted in the glucometer. A conversion factor of 1.08 has been assigned to 
this POCT to convert a whole blood glucose value to a plasma blood glucose value (Meex, 
Poncin, Chapelle, and Cavalier, 2006).  
Summary 
The association between the effects of surgical stimulus and anesthesia drugs on 
premature neonates’ metabolic response needs to be explored. The length of exposure and type 
are two variables examined in this study.  
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CHAPTER 3: RESEARCH DESIGN AND METHODS 
Problem 
Intraoperative neonatal euglycemia is not routinely monitored. Premature neonates 
receiving preoperative total parenteral infusions receive dextrose infusion during their 
intraoperative period. Surgical stimuli and drugs administered during the intraoperative 
procedures can further alter their blood glucose levels. Clinical guidelines for monitoring and 
maintaining euglycemia in neonates have been established for the preoperative and postoperative 
periods. Therefore, the establishment of intraoperative glycemic control guidelines for the 
monitoring and maintenance of euglycemia in premature neonates in order to avoid the 
occurrence of non-euglycemic events is imperative. 
Research Question 
What is the prevalence of, and risk factors for, intraoperative non-euglycemic events in 
premature neonates less than 2,500 grams? 
Aims 
Aim 1: Identify the prevalence of intraoperative non-euglycemic events in premature 
neonates under 2,500 grams. 
Aim 2: Determine the association between intraoperative and specific operative 
characteristics. 
Aim 3: Determine the association between intraoperative non-euglycemic events and 
neonatal physiological characteristics. 
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Aim 4: Determine the association between intraoperative non-euglycemic events and 
specific anesthesia provider resuscitation measures. 
Research Design 
A retrospective chart review of all eligible surgical cases from January 1 to December 31, 
2009 was used to achieve all specific aims.  Inclusion criteria included preterm neonates (< 37 
weeks) that had any type of surgical intervention with general or total intravenous anesthesia 
whose weight was <2500 grams on the day of surgery, and had complete data for all study 
variables. Exclusion criteria included premature neonates that underwent surgical procedures  
within 24 hours after birth and whose mothers were treated with beta-sympathomimetics, beta-
blockers, chlopropamide, benzothiazide diuretics, or tricyclic antidepressants in the third 
trimester (as documented in the maternal history of the neonatal medical record). Furthermore, 
preterm neonates with the following metabolic disorders were excluded: type I glycogenesis 
storage disease with glucose-6-phosphate deficiency, Beckwith-Wiedemann Syndrome, 
nesidioblastosis, islet cell adenomas, adenomatosis, or adrenal insufficiency.  
Sample 
This retrospective, descriptive study used a convenience sample of all premature neonates 
meeting inclusion criteria over a 12 month time period. All eligible cases from January 1 to 
December 31, 2009 were screened for possible inclusion.  In preparation for research, the PI 
reviewed the surgical scheduling log for January 1 to December 31, 2009 to identify potential 
study subjects. The electronic and paper charts for each potential subject were evaluated for 
inclusion and exclusion criteria. If excluded, the information obtained from the surgical 
scheduling log for that patient was immediately destroyed. The information obtained from the 
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surgical scheduling log for included subjects were destroyed upon completion of the study (see 
confidentiality plan below). The records of 200 preterm neonates were reviewed. 
Setting  
This study was conducted at The Children’s Hospital of Southwest Florida. It is 
designated as Level III neonatal facilities and a regional referral center for critically ill neonates. 
Subject Risks 
The project was a retrospective chart review. Consequently, there were no direct or 
indirect benefits to any subjects. Furthermore, there were no risks to subjects aside to a minimal 
risk for loss of confidentiality.  The study was approved by the Institutional Review Board via 
expedited review by the University of Central Florida and the study facility (Appendices L and 
M).  
Confidentiality 
In order to maintain confidentiality data collected for this study were deidentified. Each 
subject was assigned an identification number that was used to code all subject data retrieved 
from the medical record. A confidential list of subjects and their study identification numbers 
was placed in a secured file to which only the researcher has access. No unique identifying 
information was placed onto computer files. The listing of subjects and their study identification 
numbers was destroyed on completion of the study.  
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Data Collection 
 A formal data collection tool was used to obtain data (see Appendix A).  This data 
collection tool was piloted on the first 5 charts.  Also, a random double-check of 5 data points for 
each chart was conducted to ensure accuracy of the data collection tool. Data collection issues
Data Collection Procedures 
 
were not found and the tool did not require modification.  
Medical records (electronic and paper) for all surgical premature neonates meeting the 
above mentioned inclusion criteria were reviewed. All data extracted from the medical records 
were entered directly onto the Prevalence of and Risk Factors for Intraoperative Non-Euglycemia 
Events in Premature Neonates <2500 grams l Data Collection Tool (Appendix N).   
Data Analysis 
All data were entered into SPSS 16 to facilitate data analysis. Demographic data were 
examined using descriptive statistics. Study variables were examined to achieve their specific 
aims. 
Specific Aim 1: Identify the Prevalence of IONEE in Premature Neonates <2500 Grams 
The prevalence of IONEE in premature neonates is currently not known. Knowing the 
prevalence of IONEE is an essential for two reasons. First, it provides empirical evidence 
regarding the magnitude of IONEE to support the development of a clinical guideline. It 
addresses the question, “Is IONEE a common enough problem to warrant a clinical guideline?” 
Second, it establishes a baseline IONEE measure that can be used to evaluate the effectiveness of 
future interventions. 
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The variable measured for this outcome was the initial blood glucose level immediately 
after surgery. It was measured as a continuous level variable and classified into nominal (normal 
or abnormal) and ordinal (hypoglycemia, euglycemia, or hyperglycemia) as well. This variable 
was reported as ACCU-CHECK results. All values were converted by ACCU-CHECK Inform to 
an approximate plasma value.   
 Traditional epidemiological analysis was used to compute a prevalence rate for IONEE 
per 1000 surgical cases. 
Specific Aims 2-4 
 Development of a clinical guideline includes the notion of risk stratification. Specifically, 
which preterm neonate characteristics or intraoperative conditions are associated with an 
increased IONEE risk? Knowing these risk factors affords the opportunity to match the 
combination of individual and circumstantial risks with monitoring efforts to effectively 
maintain intraoperative euglycemia. Furthermore, these results will help identify potentially 
modifiable clinical actions for future research activities. 
Specific Aim 2: Determine the Association between IONEE and Specific Operative 
Characteristics 
 Independent variables included length of surgery (minutes), length of anesthesia 
(minutes), type of surgery by body system (e.g., cardiac, gastrointestinal, etc) and type of 
anesthesia (e.g., general, total intravenous anesthesia, etc.).  The dependent variable was 
presence or absence of IONEE.  
 Chi-square and odds ratio were used to evaluate the association between the presence of 
IONEE and all categorical/nominal level variables. Student’s t-test was used to evaluate the 
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association between the presence of IONEE and all continuous variables.  
Specific Aim 3: Determine the Association between IONEE and Neonatal Physiological 
Characteristics 
 Independent variables included the following: Intraoperative and postoperative 
hypothermia; intraoperative desaturation; pre-, intra- or postoperative acidosis; pre-, intra or 
postoperative hypobicarbonatemia; pre-, intra- or postoperative hypercarbia; and preoperative 
blood glucose level. The dependent variable was presence or absence of IONEE. 
 Chi-square and odds ratio were used to evaluate the association between the presence of 
IONEE and all categorical/nominal level variables. Student’s t-test was used to evaluate the 
association between the presence of IONEE and all continuous variables.  
Specific Aim 4: Determine Association between IONEE and Specific Anesthesia Provider 
Resuscitation Measures 
 Independent variables included intraoperative endotracheal tube placement, 
intraoperative administration of dextrose-containing crystalloids, nondextrose-containing 
crystalloids (e.g., saline), colloids (e.g., albumin), blood products (PRBC, platelets, FFP), 
vasopressors (e.g., Dopamine, Epinephrine, etc.) or anticholinergic drugs (e.g., Atropine, 
Glycopyrrolate). The dependent variable was presence or absence of IONEE.  
 Chi-square and odds ratio were used to evaluate the association between the presence of 
IONEE and all categorical/nominal level variables. Student’s t-test was used to evaluate the 
association between the presence of IONEE and all continuous variables. 
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Table 1. Variables Used in IONEE Study  
Variable Specific Aim 
Level of 
Measurement Measurement Issues 
Dependent Variable 
Proxy measure of 
intraoperative blood glucose 
level 
1, 2, 3, 
and 4 
 
Continuous and 
categorical 
May be reported as either ACCU-
CHEK or serum value. 
Resolution: Convert all values to 
ACCU-CHEK. 
Independent Variables 
Premature neonate weight 3 Continuous Weight on day of surgery 
Length of surgery 2 Continuous Arrival in the OR to leaving OR 
Type of surgery 2 Categorical Multiple surgeries will be reflected with multiple categories 
Length of anesthesia 2 Continuous Anesthesia administration begins to end 
Type of anesthesia 2 Categorical 
Multiple types of anesthesia will 
be reflected with multiple 
categories 
Site for blood collection 3 Categorical 
Multiple types of blood collection 
site will be reflected with multiple 
categories 
Intraoperative hypothermia 3 Nominal < 37˚ C = Yes 
Postoperative hypothermia 3 Nominal < 37˚ C = Yes 
Intraoperative desaturation 3 Nominal SaO2 < 90% = Yes 
Underlying medical history 
for neonates 3 Categorical 
Multiple medical history will be 
reflected with multiple categories      
Preoperative acidosis 3 Nominal pH < 7.30 = Yes 
Intraoperative acidosis 3 Nominal pH < 7.30 = Yes 
Postoperative acidosis 3 Nominal pH < 7.30 = Yes 
Intraoperative blood glucose 
level 3 Continuous 
May be reported as either ACCU-
CHEK or serum value. 
Resolution: Convert all values to 
ACCU-CHEK. 
Postoperative complications 
for premature neonates 3 Categorical 
Development of postoperative 
complications during the first 24 h 
of postoperative period will be 
reflected with multiple categories 
Preoperative 
hypobicarbonatemia 3 Nominal < 19 mEq/L = Yes 
Intraoperative 
hypobicarbonatemia 3 Nominal < 19 mEq/L = Yes 
Postoperative 
hypobicarbonatemia 3 Nominal < 19 mEq/L = Yes 
  
 33 
Variable Specific Aim 
Level of 
Measurement Measurement Issues 
Preoperative hypercarbia 3 Nominal > 45 mm Hg = Yes 
Intraoperative hypercarbia 3 Nominal > 45 mm Hg = Yes 
Postoperative hypercarbia 3 Nominal > 45 mm Hg = Yes 
Preoperative blood glucose 
level 3 
Continuous and 
categorical 
May be reported as either ACCU-
CHEK or serum value. 
Resolution: Convert all values to 
ACCU-CHEK. 
Endotracheal tube placement 4 Nominal  
Intraoperative intravenous 
fluid administration 
(Dextrose-containing) 
4 Nominal  
Intraoperative intravenous 
fluid administration (Non-
dextrose-containing) 
4 Nominal  
Intraoperative colloids 
administration (albumin) 4 Nominal 
 
 
 
Intraoperative blood product 
administration (PRBC, 
platelets, FFP) 
4 Nominal  
Intraoperative vasopressor 
administration 4 Nominal  
Intraoperative anticholinergic 
administration 4 Nominal  
 
The AccuCheck Inform POTC was used in this study to measure capillary and arterial 
blood glucose levels. The AccuCheck Inform has been calibrated with a reagent strip and a 
specific chip inserted in the glucometer. A conversion factor of 1.08 has been assigned to this 
POCT to convert a whole blood glucose value to a plasma blood glucose value (Meex, Poncin, 
Chapelle, and Cavalier, 2006).  
Not every variable initially identified for this study was able to be analyzed due to 
missing data. However, the variables that were analyzed shed light on possible causes for the 
development of IONEE. 
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Summary 
This chapter summarized the methods for conducting the study. Findings will be 
described in the next chapter. 
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CHAPTER 4: RESULTS 
Description of Subjects 
During the 12-months included in this review, 72 premature neonates <2500 grams 
underwent surgical procedures. Of that group, 26 met inclusion criteria for this study. Subjects 
were excluded because they were not premature on the day of surgery (n=9), they weighed more 
than 2500 grams on the day of surgery (n=35), or they did not have an anesthesia provider (n=2).   
Additionally, five subjects required more than one surgical procedure. Each procedure was 
included in this study as a separate event. Table 3 summarizes characteristics for the study 
sample. Table 4 summarizes the average weight and gestational for the study sample. 
 
Table 2. Characteristics of Premature Neonates <2500 Grams Undergoing Surgical Procedures  
Characteristic n (%) 
Gender 
   Male 
   Female 
 
      15 (57.7%) 
      11 (42.3%) 
Ethnicity  
  Caucasian 
  Black 
  Other 
 
     11 (42.3%) 
     8 (30.8%) 
     7 (26.9%) 
Weight category1
   ELBW 
 day of surgery 
   VLBW 
   LBW 
 
3 (11.5%) 
13 (50.0%) 
10 (38.5%) 
1
 
ELBW-extremely low birth weight, VLBW-very low birth weight, LBW-low birth weight 
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Table 3. Average Weight and Gestational Age on Day of Surgery of Premature Neonates  
Characteristic Mean SD 
Weight on day of surgery (grams) 1380.92 618.17 
Gestational age on day of surgery (weeks) 30.46 3.75 
 
Prevalence of IONEE 
 Of the 26 premature neonates who underwent surgical procedures, 10 (38%) experienced 
an IONEE.  All abnormal values were hyperglycemia events (see Table 4).  The average of blood 
glucose in these 10 subjects was 199 mg/dL.  
 
Table 4. Prevalence of IONEE in Premature Neonates <2500 Grams  
 Frequency Percent 
Hypoglycemia 0 0 
Hyperglycemia 10 38.5 
Euglycemia 16 61.5 
Total 26 100.0 
 
Specific Aim 1: Association between IONEE and Specific Operative Characteristics 
  Mean surgical times for IONEE subjects (71.70 + 27.03 minutes) was significantly 
longer than those with euglycemia (45.62 + 17.98 minutes; t(24) = 2.96, p=0.007).  IONEE 
subjects were in surgery about 50% longer than those with euglycemia (Mean Difference = 26.08 
minutes, 95% CI: 7.92, 44.23). There was no difference in anesthesia time (see Table 5).  Type 
of anesthesia was significantly associated with IONEE as well. All IONEE subjects received 
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general anesthesia (n=10) while none of those with regional anesthesia had an IONEE (X2(1)
 
 = 
4.875, p=0.027). No association was noted between surgical procedure and IONEE (see Table 6).  
Table 5. Association between Length of Anesthesia, Length of Surgery, and IONEE 
Operative 
Characteristic 
Mean 
(Minutes) 
Std. 
Deviation 
IONEE t (df) p 
Mean 
Difference (95% 
CI) 
Length of 
anesthesia (mins) 
105.15 53.15 Yes 
1.889 
(10.192) 
.088 
32.788 
(-5.778, 71.353) 72.21 17.21 No 
Length of surgery 
(mins) 
71.70 
 
27.03 Yes 
2.965 
(24) 
.007 
26.08 
(7.92,44.22) 45.62 17.98 No 
 
 
Table 6. Relationship between Surgical Procedures and IONEE 
Characteristic Chi-Square df p 
Type of surgical procedures 4.875 2 .087 
Type of anesthesia 4.875 1 .027 
 
Specific Aim 2: Association between IONEE and Neonatal Physiological Characteristics 
 There were no differences in presence of IONEE based on gender, ethnicity, or weight 
class. The development of IONEE was not associated with specific preoperative medical 
conditions or intraoperative temperature. Furthermore, IONEE was not associated with an 
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increased risk for postoperative complications. Tables 7 and 8 present a summary of the 
association between IONEE and neonatal physiological characteristics. 
Patients with IONEE had higher mean preoperative glucose levels (127.11 g/dL + 31.66) 
than those who did not experience IONEE (86.36 g/dL + 29.39; Mean Difference = 40.75 g/dL, 
95% CI: 13.86, 67.65; t(21)
 
 = 3.151, p=0.005). Two subjects had preoperative hyperglycemia, and 
only one of those experienced IONEE.  
Table 7. Association between Neonatal Physiological Characteristics and IONEE 
Variable Chi-Square df P 
Preoperative glucose levels .109 1 .742 
Site of blood collection 6.518 1 .011 
Preoperative pulmonary complication 8.603 1 .003 
Preoperative respiratory acidosis .266 1 .606 
Preoperative medical condition of anemia .005 1 .946 
Preexisting medical condition of sepsis .005 1 .946 
Preoperative Intraventricular Hemorrhage .396 1 .529 
Preoperative cardiac complication 3.718 1 .054 
Preoperative necrotized enterocolitis .006 1 .937 
Intraoperative temperature of premature neonates .000 1 1.000 
Postoperative metabolic acidosis 5.426 1 .020 
Postoperative complication of sepsis 1.354 1 .245 
Postoperative complication of respiratory acidosis 1.140 1 .286 
Postoperative pulmonary complications .006 1 .937 
Postoperative bleeding complication .650 1 .420 
Postoperative complication of anemia .885 1 .347 
Postoperative cardiac complications 3.291 1 .070 
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 A higher proportion of premature neonates who developed IONEE had the capillary heel 
(60%) as opposed to an arterial (40%) site for blood collection (X2(1) = 6.518, p = 0.001) . Sixty 
percent of the premature neonates that developed intraoperative hyperglycemia had their blood 
sample collected from their capillary heel, while 40% had blood sample collected from arterial 
site. In fact, premature neonates who had capillary heel as a blood collection site were more than 
10 times as likely to have hyperglycemia (OR=10.50, 95% CI: 1.5, 73.7).   
Also, premature neonates free of preoperative pulmonary complications were more prone 
to develop IONEE (X2(1)
The presence of IONEE was associated with development of metabolic acidosis (X
 = 8.60, p = .003). In fact, none of the neonates with preoperative 
pulmonary complications developed IONEE.  
2(1) = 
5.426, p=0.020). Every identified case of metabolic acidosis was in a neonate with IONEE. In 
fact, patients with IONEE had significantly lower postoperative pH values (7.19 + 0.20) than 
those not experiencing IONEE (7.35 + 0.11; Mean Difference = -.16028, 95% CI: -.32001, -
.00055; t(23)
A number of complications were not found in this sample and were excluded from 
analysis (see Table 8).Several following neonatal physiological variables were not present or 
minimal (less than five) in our data, therefore, statistical analysis were not performed in these 
variables (Table 9). 
 = -2.22, p=0.049).  
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Table 8. Association of IONEE with Neonatal Physiological Characteristics Measured with 
Independent Sample T-test  
Neonatal Characteristics t df p Mean Difference (95% CI) 
Preoperative glucose 3.151 21 .005 40.75 (13.85, 67.65) 
Preoperative pH -1.945 19 .067 -.050 (-.103, .004) 
Preoperative PCO2 -.186 19 .854 -1.286 (-15.729, 13.156) 
Preoperative Bicarbonate -1.289 19 .213 -4.230 (-11.096, 2.636) 
Intraoperative Temperature -1.145 23 .264 -.340 (-.954, .274) 
Weight (grams) on the day of surgery .571 24 .573 144.262 (-377.120, 664.64) 
Gestational age on the day of surgery 1.008 24 .324 1.525 (-1.598, 4.648) 
Postoperative temperature -1.520 23 .142 -.790 (-1.866, .285) 
Postoperative pH -2.220 10.57 .049 -.160 (-.320, -.000) 
Postoperative PCO2 1.339 10.01 .210 17.616 (-11.697, 46.929) 
Postoperative Bicarbonate -1.136 23 .268 -3.330 (-9.395, 2.734) 
 
 
Table 9. Neonatal Physiological Variables not Statistically Analyzed   
 
 
  
 
 
Specific Aim 3: Association between IONEE and Specific Anesthesia Provider Resuscitation 
Measures  
 Evaluation of resuscitation medication, intravenous fluids, and endotracheal tube 
placement found no association between these variables and the presence of IONEE (see Table 
Preoperative metabolic acidosis 
Intraoperative blood glucose level 
Postoperative necrotized enterocolitis 
Postoperative intraventricular hemorrhage 
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10). A number of intraoperative interventions were not required in this sample and were 
excluded from analysis (see Table 11).  
 
Table 10. Association between IONEE and Specific Anesthesia Provider Resuscitation Measures 
during Intraoperative Period 
Intraoperative Intervention Chi-Square df p 
Administration of saline 1.66 1 .197 
Administration of colloids .038 1 .846 
Administration of atropine 2.82 1 .093 
Administration of dextrose .038 1 .846 
Administration of dopamine .439 1 .508 
 
Table 11. Intraoperative Anesthesia Provider Interventions not Statistically Analyzed  
 
 
 
 
 
 
 
 
  
 
 
Intraoperative administration of packed red blood cells 
Intraoperative platelets administration  
Intraoperative neosynephrine administration  
Intraoperative glycopyrrolate  
Intraoperative administration of ephedrine  
Intraoperative administration of epinephrine  
Intraoperative endotracheal tube placement  
Intraoperative administration of fresh frozen plasma  
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Summary 
Almost 40% of the study sample developed hyperglycemia events as IONEE. Detailed 
discussions of variables associated with these are discussed in chapter 5. 
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CHAPTER 5: DISCUSSION 
 Anesthesia providers must understand the importance of monitoring and treating 
intraoperative non-euglycemic events in surgical premature neonates. It is believed that 
premature neonates are at higher risk of developing non-euglycemic events during their 
perioperative period because their glycogen storage is lower and their insulin hormone is 
immature (Mericq, 2006; Motoyama & Davis, 2009; Simmons, 2007). However, few studies 
have investigated the metabolic responses of neonates to surgical procedures. This study aimed 
to identify the prevalence of non-euglycemic events in a study population of 26 premature 
neonates. The study also sought to identify operative characteristics, premature neonate 
physiological characteristics, and anesthesia provider resuscitation measures associated with 
occurrence of non-euglycemic events during surgery.  
Study Aim 1: Prevalence of Intraoperative Non-Euglycemic Events (IONEE) in Premature 
Neonates < 2500 Grams  
 The main objective of this study was to determine the prevalence of IONEE in premature 
neonates less than 2500 grams undergoing surgery. It is acknowledged that both the small 
sample size (n=26) and the low representation of subjects in the ELBW group (n= 3) are study 
limitations. Because the study sample size was small, it is unclear whether the 38% (n = 10) 
occurrence of IONEE hyperglycemia is truly representative of the occurrence of IONEE in the 
larger population of premature surgical neonates.  
One possible pertinent factor requiring attention when examining IONEE occurrence rate 
is the site for blood sample collection (capillary heel or arterial). Sixty percent of IONEE events 
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had blood samples collected from their capillary heel, while 40% had blood samples collected 
from an arterial site. This difference is significant and is worthy of more detailed discussion.  
Karon et al. (2007) compared blood glucose values of capillary, arterial, and venous 
whole blood samples to the accuracy of point-of-care testing (POCT) results. Subjects were 
adults (40-87 years), and all received insulin. Laboratory plasma and capillary whole blood 
glucose levels measured during the first 5 postoperative hours did not differ (p=.88). However, 
arterial (p=.02) and venous (p=.001) blood glucose values were significantly higher than 
capillary blood glucose values. Compared with the present study, the samples differed in age, 
type of surgery, and treatment with insulin. Results suggest that the capillary heel blood glucose 
values obtained in this study were reliable. 
Slater-Maclean et al. (2008) examined the difference in blood glucose values obtained 
from capillary and arterial blood samples in 50 critically ill adult patients. They concluded 
arterial blood glucose values were more accurate than those obtained from capillary blood 
samples. Quality of blood samples collected from capillary sites in critically ill patients was 
questioned due to inadequate perfusion and possible edema at capillary sites. The presence of 
edema or hypoperfusion in capillary sites used for blood sample collection from premature 
neonates in this study is unknown. If present, this may have affected the quality of blood samples 
used for blood glucose measurements. More research is needed to determine the accuracy of 
capillary blood samples using the AccuCheck Inform instrument in critically ill surgical 
premature neonates. 
The near 40% IONEE rate in the study sample is clinically significant for anesthesia 
providers. Many anesthesia providers do not routinely monitor glucose levels in premature 
neonates during surgery (Ayers & Graves, 2001). Since the outcomes of IONEE in premature 
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neonates can be so adverse even resulting in early death, anesthesia providers cannot afford to be 
lax in not monitoring glucose levels during surgery. All subjects in this study who developed 
IONEE, developed hyperglycemia. Hyperglycemia events in premature neonates are associated 
with increased risk for intraventricular hemorrhage, osmotic diuresis, dehydration, retinopathy of 
prematurity, early death, sepsis and further release of insulin to rebound hypoglycemia events 
(Blanco et al., 2006; Garg et al., 2003; Heimann et al., 2007; Kao et al., 2006; Sharma et al., 
2009).  There is a need for blood glucose monitoring to be a standard of anesthesia practice 
during the intraoperative period for surgical neonates.   
  In addition, it is unknown if any subjects who developed IONEE received pre- or 
postoperative insulin. It is been suggested that premature neonates with immature insulin 
response (proinsulin) are at higher risk to develop hyperglycemia events (Mericq, 2006). 
Therefore, insulin infusion is needed for them to utilize the available glucose.  
Hypoglycemia events were absent in the surgical premature neonates in this study. It is 
possible that the surgical stress was not large enough to decrease blood glucose levels below 40 
mg/dL. Also, 88.5% of the study population received intravenous fluid containing dextrose 
during surgery. Since concentration of dextrose in these intravenous fluids was not measured in 
this study, further research is needed to identify any association between such fluids and IONEE.  
Study Aim: 2 Association between IONEE and Specific Operative Characteristics 
Two operative characteristics were significantly related to the occurrence of IONEE - 
type of anesthesia and the length of surgery.  
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Type of Anesthesia 
Premature neonates under general endotracheal anesthesia were more likely to develop 
IONEE. This may be because general anesthesia agents decrease insulin response, thereby 
increasing blood glucose concentrations. Anand, Phil, and Hickey (1992) examined stress 
responses of neonates undergoing cardiac operations and concluded that the general anesthesia 
group significantly decreased insulin responses after sternotomy (p=.0032). The blood glucose 
concentrations in the general anesthesia group were twice those of the total intravenous 
anesthesia group (p=.017). Although the neonates in Anand, Phil, and Hickey study were full 
term (more than 37 weeks of gestational age) and weighed more than 2500 grams, their findings 
on the influences of general anesthesia on blood glucose are consistent with the findings in this 
study.   
It is unknown what factors are responsible for this metabolic response, the surgical stress 
or the drugs administered during general anesthesia. Also, during the administration of general 
anesthesia, less amount of opioids may have been administered to control the release of 
catecholamines as a metabolic response to surgical stress since inhaled agents may potentiate the 
effects the opioids in depressing the cardiovascular system. Opioids are used during anesthesia 
administration to blunt the nociceptive effects on metabolic response.  
Duration of Surgery 
Subjects who developed IONEE in this study had significantly longer mean surgical time. 
Tsubo, Kudo, Matsuki, and Oyam in 1990 examined the decreased glucose utilization during 
long surgical procedures (mean duration = 13 hours) in adults and concluded that blood glucose 
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was higher in patients with longer surgical procedures (p=.05). Although ages and types of 
surgery differed, the association between longer surgical time and hyperglycemia is consistent.  
It is possible that since subjects with IONEE were undergoing longer surgical procedures, 
their metabolic response was higher due to increased intensity of surgical stress. Longer surgical 
procedures such as exploratory laparatomy  stresses visceral organs causing a higher release of 
catecholamines responsible for gluconeogenesis. Therefore, gluconeogenesis could have 
increased blood glucose levels in these neonates.  
Duration of Anesthesia  
No association between duration of anesthesia and IONEE was found in this study. One 
potential explanation is that anesthesia is administered during surgical procedures to minimize 
the effects of surgical stress on metabolic responses. General anesthesia agents are gamma-
amino butyric acid type a (GABAa) receptor agonists and minimize brain activity. Furthermore, 
opioids and general anesthesia blunt the nociceptive effect of surgery - catecholamine release, 
hepatic glucose release, decreased glucose utilization, and decreased insulin secretion. Another 
possible explanation is that subjects were not intubated in the operating room. Endotracheal tube 
placement can trigger a release of catecholamines. However, these neonates may have been 
intubated in the Neonatal Intensive Care Unit prior to surgery. Location of endotracheal tube 
placement was not collected.  
Type of Surgery  
There was no association between type of surgery and IONEE. It is possible that the type 
of surgeries that these neonates underwent did not cause enough surgical stress to cause a 
significant metabolic response such as IONEE. However, 80% of the IONEE population (n=8) 
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underwent abdominal surgeries and 20% (n=2) underwent vascular surgery. No IONEE events 
were noted with cardiovascular surgeries. The small sample size certainly played a role in this 
result. A larger sample may help identify whether type of surgery, length of surgery, or intensity 
of surgical stimuli are associated with IONEE.  
Study Aim 3: Association between IONEE and Neonatal Physiological Characteristics 
There was an association between IONEE and three neonatal medical conditions – 
absence of preoperative pulmonary complications, preoperative glucose levels, and postoperative 
metabolic acidosis. While this study found that premature neonates without pulmonary 
complications were more likely to develop intraoperative hyperglycemia events, there is no 
evidence suggesting that premature neonates with pulmonary complications have a higher risk of 
developing hyperglycemia. Further research is needed to clarify the association between pre-
existing respiratory disease and the development of IONEE. The small size of this study may 
have contributed to these results.  It is possible that premature neonates free of preoperative 
pulmonary complications were medicated with beta adrenergic agonist medications. These 
medications may have been used to support hypotensive events in cardiovascular complications 
such as patent ductus arteriousus. The use of these medications may cause hyperglycemia. It is 
unknown if the subjects free of pulmonary complications were receiving these drugs.  
One of the two subjects in the study with preoperative hyperglycemia developed IONEE. 
The relationship between preoperative IONEE and the occurrence of intraoperative IONEE is 
unknown. It is possible that differences in the rate of dextrose administered during the 
intraoperative period or the intensity of surgical procedures may have contributed to the 
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development of IONEE in this subject. More research is needed to identify what factors 
contributed to the development of IONEE when preoperative hyperglycemia is present. 
In addition, a significantly higher proportion of surgical premature neonates with IONEE 
developed postoperative metabolic acidosis (70%) compared to surgical neonates with 
euglycemia. These findings differ from those of Anand and Hockey (1992) where the neonates 
receiving total intravenous anesthesia  during cardiac surgery who developed IONEE had a 
significant alkalosis during the postoperative period (pH=7.55±.02; p=.01). In this study, mean 
postoperative pH was significantly lower for those with IONEE (7.19 + 0.20) than those who 
were euglycemic (7.35+0.106). The presence of acidosis is consistent with what is known about 
the metabolic response to hyperglycemia where there is an overproduction of ketoacids and a 
corresponding decrease in both plasma pH, and bicarbonate (HCO3-)
In this study, underlying medical conditions in premature neonates were examined to 
determine their relationship with IONEE in this sample. Respiratory acidosis, sepsis and 
necrotized enterocolitis were not significantly related to IONEE in this study. It is difficult to 
determine if these medical conditions contributed to IONEE since only hyperglycemia and not 
hypoglycemia occurred during the intraoperative period, which could reflect the administration 
of intravenous containing dextrose infusion. In addition, preoperative intraventricular 
hemorrhage history may represent previous episodes of hyperglycemia events in this sample 
reflecting the neonate’s inability to respond to insulin infusions or their own insulin, which could 
be a factor for the development of IONEE. However, no significant relationship was found 
between preoperative IVH and IONEE. Preoperative cardiac complications could have affected 
IONEE. Hemodynamic support with vasopressors (e.g., dopamine) may have improved 
.  
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perfusion during the intraoperative period. No relationship between IONEE and preoperative 
cardiac complications was found. 
Intraoperative hypothermia may also contribute to hypoglycemia events in premature 
neonates. However, no association between intraoperative temperature and IONEE was noted in 
this study. Intraoperative dextrose administration may have prevented hypoglycemia and 
exacerbated hyperglycemia. Postoperative complications such as respiratory acidosis, and sepsis 
were not associated with IONEE. The postoperative bleeding, anemia and cardiac complications 
were complications that were not significant in this study. This study was limited to 
complications arising within 24 hours of surgery. It is possible that subjects’ hyperglycemia was 
not severe or prolonged enough to contribute to these postoperative complications. The small 
sample size of this study may have contributed to these results. 
Study Aim 4: Association between IONEE and Specific Anesthesia Provider Resuscitation 
Measures 
Specific anesthesia provider resuscitation measures that may impact IONEE include IV 
fluids, vasopressors, and resuscitation medications. In this study, no associations between 
resuscitation measures and IONEE were found.  One possible reason is that during the 
intraoperative period these specific measures were not needed. In addition, the small size of this 
study may have contributed to these results. 
 The administration of saline and colloids could have reflected the need for the 
intraoperative volume replacement in these premature neonates. Hypovolemia may cause 
hypotensive events, which decrease perfusion and may alter the quality of a capillary blood 
sample. In addition, Atropine administration may indicate symptomatic bradycardia due to 
hypovolemia or hypoventilation. However, no significant relationship was found between 
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atropine administration and IONEE. It is possible that the duration of the bradycardia events 
were not significantly long to stimulate the metabolic responses in these neonates. Furthermore, 
intravenous solutions containing dextrose could have altered blood glucose levels, but no 
significant association between IONEE and intravenous solutions were found. 
Study Limitations 
 There were a number of limitations to this study.  The eligible sample size was small and 
there was a small amount of missing data.  The study findings are limited to only one region of 
the state of Florida. For this reason, this study results cannot be extrapolated to all premature 
neonates < 2500 grams. A prospective study with controls for sample size, achievement of equal 
weight category representation of premature neonates <2500 grams, measurement of blood 
glucose (controlling blood sample site, glucometer, human error during testing), evaluation of 
specific drugs used during anesthesia for general anesthesia and total intravenous anesthesia, and 
measurements of blood glucose levels at specific times (i.e., right after anesthesia starts, right 
after surgery begins, and at the end of anesthesia or surgery) is warranted. 
Conclusion  
The study results suggest that there is a higher incidence of IONEE, specifically 
hyperglycemia, in premature neonates < 2500 grams who are exposed to prolonged surgical 
procedures under general anesthesia. Also, those premature without preoperative pulmonary 
complications were more prone to develop IONEE. In addition, premature neonates < 2500 
grams with IONEE developed postoperative metabolic acidosis with a decreased in pH. 
The significant findings found in relation to the site of blood sample collection and the 
proportion of IONEE events reveals the capillary heel site is 10 times more likely to be 
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associated with the identification of IONEE (hyperglycemia) in premature neonates < 2500 
grams.  The question arises as to whether the point-of-care testing used (Accu-Check Inform) is 
accurate.  If the neonates were hypoperfused, this factor could have affected the quality of the 
capillary heel blood sample. Human error during POCT is another possibility.  
Implications for Nursing Practice  
The increase in number of premature neonates < 2500 grams that undergo surgical 
procedures presents challenges for anesthesia providers who support the life of these neonates 
during surgery. In addition, the occurrences of non-euglycemia events have been related to 
neurodevelopmental delay in these neonates, limiting their learning capacities. Anesthesia 
providers need to establish intraoperative guidelines for the monitoring and treatment of IONEE 
to protect these premature neonates from having these complications. As advanced nurse 
practitioners, nurse anesthetists are leaders who should be proactive in the endeavor of 
identifying actions that would improve our patient care and anesthesia practice. In addition, 
nurse anesthetists must collaborate with other neonatal health care providers to communicate to 
each other concerns and possible research questions that need to be answered to improve 
neonatal patient care. 
Recommendations for Future Research 
Further research must be done to ensure that premature neonates <2500 grams are being 
identified and adequately treated for IONEE. Additional research studies are needed to better 
understand the incidence of IONEE. Future research should include larger, prospective, 
descriptive studies with a goal of identifying risk factors for developing IONEE in a larger 
population. In addition, a prospective study needs to be conducted to evaluate the factors that 
  
 53 
could have contributed that premature neonates with IONEE blood sample site was capillary 
blood.  Outcomes associated with IONEE, including mortality, morbidity, and length of stay 
needs to be identified. 
The findings of this study suggest that anesthesia providers must closely examine the 
metabolic responses of surgical premature neonates. Because premature neonates are more prone 
to developing IONEE, guidelines for monitoring and treating IONEE are a clinical practice 
necessity. Factors such as site for blood glucose collection and hypoperfusion must be 
considered when monitoring blood glucose levels in premature neonates. In addition, 
complications such as postoperative metabolic acidosis may be preventable if intraoperative 
hyperglycemia is treated. More research is needed to clarify the association between length of 
surgery, type of anesthesia, and IONEE.  Also, examination of the intensity of stress in longer 
surgeries and specific drugs administered during general anesthesia is warranted. Further studies 
can contribute to evidence-based practice for the prevention of IONEE, resulting in positive 
outcomes on quality of life for premature neonates. 
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  Research Studies (N = 4)                     Pending (N = 2)                   Background Articles (N = 12) 
 
 
 
Databases:  CINAHL, MEDLINE, & Cochrane Database of Systematic Reviews 
N = 18 
LIMITS: AND “metabolic response” & “operative stress” or “surgical stress” & “infants” 
N = 14 
                                LIMITS: English, human, 0-1 month of age 
N = 10 
LIMITS: Review of abstracts to exclude works that include metabolic response to surgical 
stress after 24 hours of postoperative period. 
N = 3 
Ancestry Approach: Review of bibliographies to identify additional works on metabolic 
response to surgical stimulus. 
N = 15 
Excluded 4 
Excluded 4 
Excluded 7 
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           Research Studies (N = 11)                        Pending (N = 3)               Background Articles (N = 2) 
 
 
 
 
 
Databases: CINAHL, MEDLINE & Cochrane Database of Systematic Reviews 
N = 41 
LIMITS: And “metabolic response” and “opioids” or “inhalant agents” 
N = 38 
LIMITS: English, human, 0-1 month of age 
N = 29 
LIMITS: Review of abstracts to exclude works that involve postoperative anesthesia pain management in 
surgical neonates. 
N = 20 
4 Excluded 
9 Excluded 
11 Excluded 
Ancestry Approach: Review of bibliographies to identify additional works on metabolic response to 
anesthesia drugs. 
N = 16 
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APPENDIX C: EVALUATION MATRIX FOR RECORDING STRENGTHS AND 
WEAKNESSES OF STUDIES FOR A LITERATURE REVIEW ON METABOLIC 
RESPONSE TO SURGICAL STRESS 
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Authors Yr 
of 
Pub 
Major Strengths Major 
Weaknesses 
Conclusions Level of 
Evidence 
Chawls 
et.al. 
1995 Measures 
preoperative sepsis, 
bacterial or severe 
inflammatory injury 
effect on the 
postoperative 
metabolic response 
in infants after 
surgery. 
All surgical 
procedure were 
abdominal 
(gastroschisis, 
tracheoesophageal 
fistula, colostomy, 
and correction of 
malrotation bowel. 
Infants were older 
than 33 days and 
did not specify if 
they were 
premature. 
 
Small sample (12 
subjects). 
The acute 
underlying illness 
(sepsis, bacteremia 
or severe 
inflammatory 
process) determines 
postoperative 
measured energy 
expenditure. 
8 
Heimann 
et al. 
2007 Large sample (252 
premature neonates) 
It correlates 
morbidity (IVH, 
ROP and sepsis) with 
repetitive events of 
hyperglycemia. 
 
Retrospective 
study could have 
missed data. 
Necrotizing colitis 
is not correlated to 
hyperglycemia in 
this study. 
A positive 
correlation was 
found between low 
gestational age (<27 
weeks), high blood 
glucose levels 
(>150mg/dL) and 
more episodes of 
hyperglycemia. 
Also IVH was 
higher in low 
gestational age (<27 
weeks). 
10 
Powis et 
al. 
1998 Intraoperative and 
postoperative 
analgesia varied 
slightly. 
Metabolic rate was 
measured during 
preoperative and 
postoperative 
periods.  
Small population 
of neonates (total 
of infants and 
children was 10). 
Subjects were 
receiving dextrose 
or TPN 
intraoperatively 
which could have 
Infants and children 
do not increase their 
whole body protein 
turnover or 
metabolic rate after 
major abdominal sx. 
Perhaps is due to 
diversion of protein 
synthesis from 
10 
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Authors Yr 
of 
Pub 
Major Strengths Major 
Weaknesses 
Conclusions Level of 
Evidence 
affected 
measurement of 
protein flux. 
The variation 
among surgical 
time was too wide 
(28-285 minutes); 
therefore 
metabolism could 
have been affected 
differently among 
subjects. 
growth to tissue 
repair. 
Reynolds 
et al. 
2008 Subjects were 
assigned randomly.  
Analgesia was 
administered equally 
to control surgical 
stress and measure 
postoperative ability 
to obtain positive 
protein balance. 
Only 13 neonates 
participated in 
study. 
Surgical repairs of 
gastroschisis were 
not equal in every 
case; therefore, 
surgical stimulus 
was not equal.  
Neonates were able 
to achieve positive 
protein balance 
after amino acids 
were administered 
parentally. 
12 
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Authors Yr 
of 
Pub 
Major Strengths Major 
Weaknesses 
Conclusions Level of 
Evidence 
Anand et al. 1992 Randomized 
sample. 
Dextrose infusion 
was standardized 
among subjects. 
Hormonal and 
metabolic 
response was 
measured during 
different stages 
of surgery. 
Sample underwent 
five different 
cardiac surgeries; 
therefore, surgical 
stress could have 
varied among 
them. Sample too 
small for solid 
conclusions. 
Physiologic 
responses to stress 
are attenuated with 
deep anesthesia and 
postoperative 
analgesia. 
13 
Barratt et al. 2002 Excluded patients 
with cardiac, 
respiratory, 
muscular, 
neurological, 
renal, 
hematological, 
drug dependency 
or psychiatric 
disease. Most of 
surgeries were 
major abdominal 
surgeries.  
Cortisol, insulin 
and glucagon 
were measured 
pre and 
postoperatively. 
Epidural 
anesthesia was 
used 
intraoperatively 
and 
postoperatively. 
Validity and 
reliability are not 
specified for all 
instruments. 
All subjects were 
adults. 
Multimodal 
analgesia and IV 
Nutrition preserves 
total body protein 
and fat. 
12 
Bell, et al. 2004 All 17 subjects 
received dextrose 
5% with normal 
saline 45% 
Infants’ history of 
prematurity is not 
specified. 
Instruments and 
Remifentanyl vs. 
fentanyl/morphine 
techniques for stress 
control during sx 
8 
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of 
Pub 
Major Strengths Major 
Weaknesses 
Conclusions Level of 
Evidence 
before 
rewarming. 
Blood samples 
were obtained 
Prebypass, during 
bypass and 
postbypass. 
Randomized 
sample. 
their validity are 
not specified.  
Variation on 
preexisting 
conditions and on 
induction drugs 
(ketamine vs. 
thiopenthotal). 
did not show 
differences on stress 
response. 
Bouwmeester 
et al. 
2001 Randomized and 
double-blind 
study. 
Compares 
neonates stress 
response control 
with older 
children stress 
responses. 
Anesthesia 
management was 
standardized. 
Hormones and 
metabolic 
response were 
measured during 
different surgical 
and postoperative 
stages. 
Twenty-two 
different surgical 
procedures were 
performed. 
Only one 
instrument is 
identified as 
validated. 
Continuous infusion 
of morphine does 
not provide any 
major advantages 
over intermittent 
morphine boluses 
for postoperative 
analgesia in 
neonates and 
infants. 
Neonates receiving 
postoperative 
continuous 
morphine  showed 
higher blood 
glucose levels.  
 
 
 
13 
 
Crozier et al. 
1993 Feeding protocol 
was standardized 
for every subject. 
Gestational age 
was the same in 
both groups. 
Elective vs 
emergency c/s 
stress was 
compared. 
Emergency c/s 
subjects had lower 
weight and 
APGAR SCORES 
which could have 
affected blood 
glucose 
homeostasis 
during 
extrauterine 
transition. 
Cortisol and blood 
glucose levels were 
lower during a 
transient period on 
c/s with induced 
with Etomidate. 
12 
Gruber et al. 2001 Hormones and 
metabolic 
Anesthesia 
induction and 
Fentanyl with or 
without midazolam 
10 
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Authors Yr 
of 
Pub 
Major Strengths Major 
Weaknesses 
Conclusions Level of 
Evidence 
response were 
measured during 
different stages 
of cardiac 
surgery. 
No dextrose 
intravenous 
infusion was 
administered 
intraoperatively. 
management were 
not standardized. 
Four types of 
cardiac surgery 
were specified; 
therefore some 
variability may 
exist among stress 
responses during 
surgery. 
Duration of deep 
hypothermic 
cardiopulmonary 
arrest varied 
among groups. 
do not prevent 
hormonal or 
metabolic response 
in infants 
undergoing cardiac 
surgery. 
Kaussman et 
al. 
2001 Used changes in 
glucose, lactate 
and mixed 
venous oxygen 
saturation to 
indirectly assess 
depth of 
anesthesia. 
Subjects were 
randomized. 
BIS has not been 
validated in 
pediatric 
population. 
Cerebral perfusion 
pressure was not 
measured or 
compared to BIS 
in the study. 
There is not a 
relationship 
between the BIS 
and hemodynamic, 
metabolic or 
hormonal indices of 
anesthetic depth. 
11 
Schricker et 
al. 
2004 Subjects were 
assigned 
randomly. 
Blood samples 
were during 
perioperative 
period to 
compare 
baselines with 
after treatment 
levels. 
Validity and 
reliability of 
instruments are 
not identified. 
Perioperative 
hypocaloric 
dextrose infusion 
and epidural 
analgesia saves 
more than 100 g of 
lean body per day. 
10 
Simons et al. 2005 Subjects were 
allocated 
randomly. 
Placebo and 
morphine effects 
Validity and 
reliability of 
instrument were 
not specified. 
Blood sample was 
Continuous 
morphine infusion 
decreased plasma 
epinephrine and 
norepinephrine in 
10 
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of 
Pub 
Major Strengths Major 
Weaknesses 
Conclusions Level of 
Evidence 
were compared. 
 
not able to be 
collected from 
some subjects (n = 
13). 
ventilated preterm 
neonates. 
Terajima et 
al. 
2000 Patients with 
previous history 
of metabolic or 
endocrinologic 
disorders such as 
diabetes, 
excessive obesity 
or abnormal 
hepatic or renal 
function were 
excluded. 
Subjects were 
randomly 
assigned. 
Different glucose 
infusion 
concentrations 
were used in this 
study. 
Validity and 
reliability of 
instruments were 
not specified. 
The glucose 
tolerance of patients 
under general 
anesthesia is 
determined by the 
intensity of surgical 
stress. Insulin 
excretion is 
preserved during 
minor surgery when 
glucose infusion 
was administered  at 
0.1-0.2g/kg/h under 
general anesthesia 
with Sevoflurane. 
9 
Weale et al. 2004 Four different 
concentrations of 
remifentanil 
infusions were 
administered. 
Anesthesia 
management was 
standardized for 
every case. No 
dextrose infusion 
was administered 
during 
perioperative 
period. 
 
 
 
This study was 
limited only to 
pre-bypass stress 
stimulus; 
therefore, the 
release of NPY 
could have been 
limited. Nine 
different cardiac 
surgeries were 
performed which 
could alter the 
intensity of 
surgical stress 
among subjects. 
Cortisol should 
have been 
measured in every 
Remifentanil 
infusion greater 
than 1.0 ug/kg/min 
decreases glucose 
increase and 
tachycardia related 
to pre-bypass stress 
stimulus. 
Remifentanil may 
cause bradycardia in 
neonates. 
10 
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of 
Pub 
Major Strengths Major 
Weaknesses 
Conclusions Level of 
Evidence 
blood sample to 
correlate increases 
with different 
surgical 
stimulations. 
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Code Patient Risk Level 
0 Sepsis, bacteremia or inflammatory injury 
1 Hyperglycemia  
2 Major abdominal surgery 
3 Cardiac surgery 
4 Major surgeries 
5 Metabolic extrauterine transition  
6 Mechanical ventilation  
7 Minor surgery 
Code Care Setting 
1 Neonatal Intensive Care Unit 
2 Operating room 
3 Preoperative period 
4 Intensive Care Unit 
5 Pediatric Intensive Care Unit 
Code  Topics Presented 
1 Energy expenditure response in sick surgical infants 
2 Hyperglycemia affects mortality in premature infants <1500 g. 
3 Changes in whole-body protein flux and metabolism rate after major abdominal 
surgery. 
4 Postoperative protein positive balance 
5 Hormonal and metabolic response to stress with deep anesthesia 
6 Hormonal and metabolic response after analgesia administer intra and 
postoperatively period. 
7 Cortisol and blood glucose levels in term neonates after mother been induced with 
etomidate and barbiturate. 
8 Glucose infusion effect during minor surgery under general anesthesia. 
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Authors  Yr of 
Pub 
Population Discussed Risk 
Level 
Care 
Setting 
Topics 
Presented 
Chwals et al. 1995 Sick infants older than 33-67 
days old. 
0 1 1 
Heimann et al. 2007 Low gestational age <27 weeks 1 1 2 
Powis et al. 1998 Infants and children (2 days-3 yr 
old) 
2 1 3 
Reynolds et al. 2008 36 weeks gestational age, 1-2 
days old 
2 1, 2 4 
Anand et al. 1992 Term neonates from 5-9 days old 
with congenital heart disease 
3 1, 2 5 
Barratt et al. 2002 Adults under major abdominal 
surgery older than 21 but 
younger than 80 years old. 
2 3, 4 3 
Bell et al. 2004 From 4-108 months old children 3 2 5 
Bouwmeester 
et al. 
2001 Children aged 0-3 years 4 1, 2, 4 6 
Crozier et al. 1993 38-40 weeks old neonates 5 1, 2 7 
Gruber et al. 2001 Infants < 6 months old 3 1, 2, 5 6 
Kussman et al. 2001 Infants 3-4 months 3 2, 8 5 
Schricker et al. 2004 Adults 64-80 years old. 2 3, 4 3 
Simons et al. 2005 Neonates 27.5-32.1 weeks of 
gestational age 
6 1 6 
Terajima et al. 2000 53-62 year old adults 7 2 8 
Weale et al. 2004 Children under five years old 3 2 5 
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Authors Year of 
Publication 
Article Focus 
Chwals et al. 1995 How preoperative illness determines increases in energy 
expenditure response to surgical procedures. 
Heimann et al. 2007 How repetitive hyperglycemia events in low gestational 
neonates determines their mortality. 
Powis et al. 1998 Changes on whole-body protein and metabolic rate after 
major abdominal sx in infants and children. 
Reynolds et al. 2008 Are 1-2 day old neonates capable to obtain a positive 
protein balance after parenteral amino acids are administer 
when they undergo major abdominal sx? 
Anand et al. 1992 How deep anesthesia and postoperative analgesia 
improves mortality and decreases metabolic response to 
surgical stress. 
Barratt et al. 2002 Effects of multimodal analgesia on total body protein loss. 
Bell et al. 2004 How analgesia techniques affects stress response. 
Bouwmeester et al. 2001 How continuous or intermittent morphine affects the 
hormonal and metabolic stress responses in 0-3aged years 
children undergoing major surgeries. 
Crozier et al. 1993 Measure the effect of etomidate and barbiturate in 
metabolic extrauterine transition of full term neonates. 
Gruber et al. 2001 Control the metabolic and hormonal response with 
fentanyl with and without midazolam in infants 
undergoing cardiac surgery. 
Kussman et al. 2001 Compared the BIS reading with the metabolic response of 
infants undergoing cardiac surgery with different plasma 
fentanyl levels. 
Schricker et al. 2004 How pain control (epidural vs. PCA morphine)  in patients 
undergoing abdominal surgery, suppresses amino acid 
oxidation. 
Simons et al. 2005 Measured the effects of morphine on stress response due 
to mechanical ventilation. 
Terajima et al. 2000 How glucose infusion undergoing minor surgery under 
general anesthesia may prevent hyperglycemia, elevation 
of FFA and ketone bodies.  
Weale et al. 2004 How remifentanil infusion may alter blood glucose 
concentration during cardiac surgery stress stimulus. 
 
  
 73 
APPENDIX H: FINDINGS IN REVIEW ARTICLES FOR METABOLIC RESPONSE 
FOR SURGERY AND ANESTHESIA DRUGS IN NEONATES 
  
 74 
 
Authors Year of 
Publication 
Findings 
Chwals et al. 1995 Preoperative metabolic parameters are a more accurate 
reflection of injury severity. Postoperative metabolic 
response 
Heinaman et al. 2007 Repetitive hyperglycemia events in low gestational age 
neonates (<27 weeks) increases mortality. 
Powis et al. 1998 Whole-body protein flux and metabolic rate does not 
change after major abdominal surgery in infants and 
children. 
Reynolds et al. 2008 Neonates undergoing metabolic stress after abdominal 
surgery shortly after birth are capable of obtain a positive 
protein balance when parenteral amino acids are 
administered. 
Anand et al. 1992 Physiologic responses in neonates under cardiac surgery 
are attenuated with deep anesthesia and postoperative 
analgesia. Also mortality decreases when this stress is 
attenuated. 
Barratt et al. 2002 Multimodal analgesia with IV nutrition preserves total 
body protein loss. 
Bell et al. 2004 Remifentanil and fentanyl/morphine techniques equally 
control cardiac surgical stress response. 
Bouwmeester et al. 2001 Continuous infusion of morphine does not provide any 
major advantages over intermittent morphine boluses for 
postoperative analgesia in neonates and infants. 
Neonates receiving postoperative continuous morphine 
showed higher blood glucose levels. 
Crozier et al. 1993 Etomidate decreased the cortisol and blood glucose levels 
of neonates that born from emergency C/S. 
Gruber et al. 2001 Fentanyl with or without midazolam cannot completely 
suppress the hormonal and metabolic response in infants 
undergoing cardiac surgery. 
 
Kussman et al. 
2001 There is not relationship between the BIS and 
hemodynamic, metabolic, or hormonal indices of 
anesthetic depth. 
Schricker et al. 2004 Perioperative epidural analgesia and hypocaloric dextrose 
infusion suppress postoperative amino acid oxidation. 
Simons et al. 2005 Continuous morphine infusion decreases plasma 
noradrenaline concentration in preterm neonates stressed 
by mechanical ventilation. 
Terajima et al. 2000 The administration of glucose infusion at 0.1-0.2/kg/h 
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Authors Year of 
Publication 
Findings 
during minor surgery under sevoflurane general anesthesia 
prevented hyperglycemia. 
Weale et al. 2004 Remifentanil may cause bradycardia in neonatal surgical 
patients. Remifentanil infusion greater than 1.0ug/kg/ min 
may suppress glucose levels in blood during cardiac 
surgery in children younger than 5 years old. 
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Authors Yr of Pub 
 
Article Focus Metabolic 
Response to 
Surgery or 
Anesthesia 
Agus & Jaksic 2002 Nutritional support for ill neonates and 
children. 
Surgery 
Chwals 2004 Enteral and parenteral nutrition in 
premature surgical neonates. 
Surgery 
Eaton 2003 Impaired energy metabolism during 
neonatal sepsis: the effects of glutamine. 
Surgery 
Hillier 2004 Neonatal anesthesia management 
considerations. 
Anesthesia  
Hulzebos & Saur 2007 Energy requirements for newborn 
infants. 
Surgery 
Hume et al. 2002 Developmental disorders of glucose 
metabolism in premature neonates. 
Surgery 
Jaksic & Shew 2004 Metabolic Response to illness and 
operation in full term and premature 
neonates. 
Surgery 
Kninouchi 2003 Anesthetic considerations for the 
management of very low and extremely 
low birth weight infants. 
Anesthesia  
Owens & Musa 2009 Nutrition support after neonatal cardiac 
surgery. 
Surgery 
Parish & Bhatia 2008 Early aggressive nutrition for the 
premature infant. 
Surgery 
Pierro & Eaton 2006 Nutrition in the neonatal surgical 
patient. 
Surgery 
Pierro 2002 Metabolism and nutritional support in 
the surgical neonate. 
Surgery 
Pierro & Eaton 2008 Metabolism and nutrition in the surgical 
neonate. 
Surgery 
Rao 2009 Early introduction of lipids to 
parenterally-fed preterm infants. 
Surgery 
Valentine & 
Puthoff 
2007 Enhancing parenteral therapy for the 
neonate. 
Surgery 
Yu 2005 Optimizing nutrition in preterm infants, 
improves extrauterine growth 
restriction. 
Surgery  
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Author Yr  
of 
Pub 
Country Independent 
Variables 
Dependent 
Variables 
Study 
Design 
Sample 
Size 
Sample 
Character 
Sampling 
Method 
How 
Data  
Collected? 
Instrument Valid/ 
Reliable 
Surgery 
or 
Anesthesia 
Chwals 
et al. 
1995 U.S. Preoperative 
sepsis, 
bacteremia or 
inflammatory 
injury. 
Measured 
energy 
expenditure 
Descriptive  12 infants 33-67 days old 
Critically ill  
Convenience 
sample 
CRP concentration 
measured postop day 
2,5,8 
Indirect 
calorimetry 
Support 
by other 
research 
studies 
Surgery  
Heimann 
et al. 
2007 U.S. 27 weeks 
gestational age 
Mortality 
and 
hyperglycemia 
events 
Retrospective  252 
premature 
infants 
Repetitive 
hyperglycemia 
events 
Convenience  Review charts Not described n/a Surgery  
Powis et 
al. 
1998 England  Major 
abdominal 
surgery 
Protein flux and 
energy 
metabolism  
Prospective  10 infants 
and children 
(2 days-3 
years old) 
Major abdominal 
surgery with 
operative stress 
score > 7 
Convenience  Energy expenditure 
calculated with 
respiratory quotient 
carbon dioxide 
production/ oxygen 
consumption. Indirect 
calorimeter used with 
leucine IV infusion. 
Computerised 
indirect 
calorimeter 
Ethanol burned 
(96% volume) 
with error less 
than 3%. 
Surgery  
Reynolds 
et al. 
2008 U.S. Gastroschisis 
abdominal 
surgery 
Immediate 
postoperative 
protein 
Prospective  13 neonates 
2 kg wt 
36>weeks 
gestational 
age 
1-2 days old 
NTISS-28 
SNAP-8 
Major abdominal 
surgery first two 
days of life. 
Randomized  Nitrogen balance was 
calculated from nitrogen 
intake minus urine 
nitrogen output. Blood 
sample was taken from 
arterial line for 
creatinine, BUN, 
glucose, and ammonia. 
Neoscope 
(indirect 
calorimeter) 
Combustion of 
absolute ethyl 
alcohol. 
Surgery  
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Author Yr  
of 
Pub 
Country Independent 
Variables 
Dependent 
Variables 
Study 
Design 
Sample 
Size 
Sample 
Character 
Sampling 
Method 
How 
Data  
Collected? 
Instrument Valid/ 
Reliable 
Surgery 
or 
Anesthesia 
Anand et al. 1992 U.S. Halothane-
morphine vs. 
high dose 
fentanyl 
Metabolic response to 
surgical stress  
Experimental  30 
neonates 
Neonates 
undergoing 
cardiac 
surgery 
Randomly 
assigned 
Arterial blood 
sample 
collected; 
before 
surgery, 
before CPB, 5 
minutes after 
circulatory 
arrest ends, 
end of sx, and 
6,12,& 24 hrs  
postop. 
Radioimmnoassay 
-insulin, glucagon 
and beta-endorphin  
Double-isotpe 
radioenzymatic 
assay  
-steroid hormones 
Specific enzymatic 
assays-glucose, 
lactate, pyruvates, 
acetoacetate, 3-
hydroxybutyrate 
and alanine 
Coefficient of 
variation: 
Radio-<5%, 
Radio-enzymatic-
<10%, and Specific 
assays < 3%. 
Anesthesia 
Barratt et al. 2002 Australia Multimodal 
analgesia 
Total Body Protein Experimental  47 adults 22-79 year 
old adults 
with upper 
abdominal 
surgery 
Randomized  Total body 
protein, 
nitrogen 
balance, 
arterial blood 
gases, pain 
scores and  
In vivo neutron 
activation analysis 
Coefficient of 
variation 3%. 
Anesthesia  
Bell et al. 2004 UK Remifentanil 
vs. fentanyl/ 
morphine 
Pain and surgical stress  Experimental  17 
children 
4-108 
months old 
with 
cardiac 
surgery 
Randomized  Blood 
samples for 
glucose and 
cortisol from 
induction-24 
hrs postop. 
HR, MAP, 
tachycardia 
and 
bradycardia 
were recorded 
Not specified Not specified Anesthesia 
Bouwemmester 
et al. 
2001 Netherlands Major surgery, 
effects of 
continuous 
and 
Hormonal and 
metabolic surgical  
stress response 
Experimental  
Double-blind 
204 
children 
Children 
aged 0-3 
years 
Randomized  Arterial blood 
samples to 
measure Epi, 
NE, insulin, 
Surgical Stress 
Score, VAS and 
COMFORT scales 
for pain, HPLC 
Authors only 
mentioned validation 
for COMFORT scale 
Anesthesia 
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Author Yr  
of 
Pub 
Country Independent 
Variables 
Dependent 
Variables 
Study 
Design 
Sample 
Size 
Sample 
Character 
Sampling 
Method 
How 
Data  
Collected? 
Instrument Valid/ 
Reliable 
Surgery 
or 
Anesthesia 
intermittent 
morphine 
glucose and 
lactate. Urine 
collected for 
protein loss 
test. 
(Epi and NE), 
Insulin IRMA CT 
kit, standardized 
labanalyzers 
(glucose, lactate, 
total bilirubin and 
plasma and urinary 
creatinine) and 
amino acid 
analyzer. 
 
 
 
Crozier et al. 1993 Germany Etomidate and 
methohexitone 
administration 
Adrenocortical and 
metabolic adaptation of 
the neonate 
Experimental  40 
neonates  
Delivered 
by 
cesarean 
section 
under 
general 
anesthesia 
Randomized  Blood 
samples; 1st 
from 
umbilical 
cord, 2h 
Radioimmunoassay 
kit for cortisol 
measurement. 
Etomidate 
measured with gas 
chromatography. 
and 
6h postpartum 
from heel.  
Radioimmunoassay 
sensitivity is 5.5 
nmol/L. 
Gas chromatography 
sensitivity is 
2.5ng/mL. 
 
Gruber et al. 2001 U.S. Fentanyl 
bolus, fentanyl 
infusion, and 
fentanyl-
midazolam 
infusion. 
Stress response  Experimental  
randomized 
double-blind 
45 
infants < 
6months 
Infants 
undergoing 
cardiac 
surgery 
Randomized  Arterial blood 
samples for 
epi, NE, 
cortisol, 
adrenocortical 
hormone, 
glucose, and 
lactate after 
induction, 
sternotomy, 
15 min after 
bypass, at the 
end of sx and 
24 hrs postop. 
Single-isotope 
radioenzymatic 
assay for NE and 
Epi levels. 
Chemilumin-
escence for cortisol 
levels. 
Immunoradio-
metric assay for 
ACTH levels. 
STAT profile ultra 
for lactate and 
glucose. 
Variability/Sensitivity 
Epi 14.6%/29.2% 
NE 4.7%/11.2% 
ACTH 1%/2.5% 
Cortisol 6.5%/10.1% 
Variability of lactate 
6.0% glucose 5.0%. 
 
Kussman et al. 2001 U.S. Stress Bispectral index (BIS) Prospective  19 Infants Randomized  Mean arterial Single-isotope Variability/Sensitivity  
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Author Yr  
of 
Pub 
Country Independent 
Variables 
Dependent 
Variables 
Study 
Design 
Sample 
Size 
Sample 
Character 
Sampling 
Method 
How 
Data  
Collected? 
Instrument Valid/ 
Reliable 
Surgery 
or 
Anesthesia 
response and 
plasma 
fentanyl levels 
neonates 
and 
infants<6 
mo 
undergoing 
cardiac 
surgery 
pressure, 
heart rate and 
arterial blood 
samples were 
obtained for 
NE, Epi, 
ACTH, 
cortisol, 
glucose, 
lactate and 
fentanyl 
levels. 
radioenzymatic 
assay for NE and 
Epi levels. 
Chemilumin-
escence for cortisol 
levels. 
Immunoradio-
metric assay for 
ACTH levels. 
Chromatography 
for detection of 
glucose and lactate. 
Epi 14.6%/29.2% 
NE 4.7%/11.2% 
ACTH 1.0%/2.5% 
Cortisol 6.5%/10.1% 
Schricker et al. 2004 Germany  Epidural 
anesthesia and 
Dextrose 10% 
infusion 
Amino acid oxydation Prospective 
randomized 
control trial 
20 adults 
64-68 
year old 
Adults 
undergoing 
hemi- 
colectomy 
and 
sigmoid 
colectomy 
Randomized  Expired 
breath 
samples to 
determine 
CO2 isotope 
enrichments 
and arterial 
blood gases to 
determine 
whole body 
leucine and 
glucose 
kinetics. 
Indirect 
calorimetry, Gas 
Chromatography 
Mass Spectrometry, 
Isotope ratio-Mass 
Spectrometry, 
glucose Analyzer2, 
Synchron CX 
system(lactate), and 
Radioimmunoassay 
(insulin, cortisol 
and glucagon) 
Not specified  
Simons et al. 2005 U.S. Morphine 
 
plasma 
adrenaline/noradrenaline 
concentrations 
blinded 
randomized 
placebo 
control trial     
126  (<3 
days old) 
neonates 
preterm 
neonates 
(28.4-32.1 
gestational 
age) on 
Randomized Blood 
samples were 
taken before 
and after 
administration 
High performance 
liquid 
chromatography 
with flurimetric 
detection was used 
for measurements 
on plasma 
concentration of epi 
and NE. 
Not specified  
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Author Yr  
of 
Pub 
Country Independent 
Variables 
Dependent 
Variables 
Study 
Design 
Sample 
Size 
Sample 
Character 
Sampling 
Method 
How 
Data  
Collected? 
Instrument Valid/ 
Reliable 
Surgery 
or 
Anesthesia 
ventilator 
<8hrs  
of analgesia  
drug 
 
Terajima & 
Ogawa 
2000 Japan Glucose Usage of energy sources 
during minor surgery 
Experimental  40 adults 
53-62 
years old 
Adults 
undergoing 
tympano-
plasty or 
skin 
grafting 
under 
general 
anesthesia 
with 
sevoflurane 
Randomized  Blood sample 
collected 20 
min before 
induction, and 
1 and 2 hour 
after glucose 
infusion. 
Urine sample 
was obtained 
before 
induction and 
2 hours after 
glucose 
infusion was 
started. 
Glucose –oxidase 
method 
-glucose 
Acyl CoA oxidase 
method 
-Free fatty acid 
Williamson’s 
enzyme method 
-acetoacetate 
Radioimmunoassay 
-immunoreactive 
insulin 
Not specified  
Weale et al. 2004 UK Remifentanil 
infusion 
Stress response during 
pre-bypass phase of 
pediatric cardiac 
surgery. 
Experimental  49 
infants 
and 
children 
under 
five 
years old 
Infants and 
children 
under 5 
years old 
undergoing 
cardiac 
surgery 
Randomized Blood sample 
was obtained 
at induction, 
pre-surgery, 5 
min after 
sternotomy 
and 
immediately 
pre-bypass. 
Blood glucose 
was measured 
with every 
blood sample 
taken.  
Cortisol and 
One touch-glucose 
oxidase method, 
Chemiluminescence 
for plasma cortisol 
Immunoassay kit 
for neuropeptide Y 
One touch coefficient 
variation % 
Chemiluminescence 
variability 6.4% 
Intra-assay variability 
less than 5%. 
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Author Yr  
of 
Pub 
Country Independent 
Variables 
Dependent 
Variables 
Study 
Design 
Sample 
Size 
Sample 
Character 
Sampling 
Method 
How 
Data  
Collected? 
Instrument Valid/ 
Reliable 
Surgery 
or 
Anesthesia 
neuropeptide 
Y were 
measured in 
first and last 
sample. Heart 
rate and mean 
arterial 
pressure were 
recorded. 
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APPENDIX L: UCF IRB APPROVAL 
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APPENDIX M: LMHS IRB APPROVAL 
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APPENDIX N: PREVALENCE OF AND RISK FACTORS FOR INTRAOPERATIVE 
NON-EUGLYCEMIA EVENTS IN PREMATURE NEONATES <2500 GRAMS  
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Data Collection Tool 
 
Subject Code #  
Demographic Data: 
Gestational Age on the day of surgery: _________weeks            Gender: (1) Male (2) Female 
Ethnicity: (1) Caucasian (2) Black (3) Hispanic (4) Asian (5) Other 
Weight on the day of surgery: (1) < 2,500 grams (2) < 1,500 grams (3) < 750 grams  
Gestational age at birth: ________weeks 
Exclusion criteria: 
Surgical procedures immediately after birth (1) Yes (2) No 
Mother treated with following drugs during third trimester: 
a. Beta-sympathomimetics (1) Yes (2) No  
b. Beta-blockers (1) Yes (2) No  
c. Chlopropamide (1) Yes (2) No  
d. Benzothiazide diuretics (1) Yes (2) No  
e. Tricyclic antidepressants (1) Yes (2) No 
f. Neonatal metabolic disorders:  
g. Type I glycogenesis storage disease with glucose-6-phosphate deficiency (1) Yes (2) No 
h. Beckwith-Wiedemann Syndrome (1) Yes (2) No  
i. Nesidioblastosis (1) Yes (2) No  
Exclusion criteria: 
a. Islet Cell Adenomas (1) Yes (2) No 
b. Adenomatosis (1) Yes (2) No 
c. Adrenal insufficiency (1) Yes (2) No 
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Operative characteristics: 
a. Length of surgery _______minutes 
b. Type of surgery: 
1. Cardiac_____ 
2. Abdominal_____ 
3. EENT______ 
4. Thoracic______ 
5. Neuro_______ 
c. Length of anesthesia_________minutes 
d. Type of anesthesia: 
1.  General anesthesia_______ 
2. TIVA______________ 
3. Regional anesthesia____________ 
Neonatal physiological characteristics: 
Preoperative underlying medical history of premature neonates 
1. Sepsis 
2. Necrotizing enterocolitis 
3. Respiratory distress 
4. Bronchopulmonary dysplasia 
5. Intraventricular hemorrhage 
6. Pulmonary hypertension 
Preoperative glucose level:  
1. ACCUCHECK value_______ or Serum value 
2. Normal (glucose level 40-150 mg/dL): ________mg/dL 
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a. Normoglycemia (glucose level 40-150 mg/dL) (1) Yes (2) No  
3. Abnormal (glucose level < 40 or > 150 mg/dL): _______mg/dL 
a. Hypoglycemia (glucose level <40 mg/dL) (1) Yes (2) No  
Hyperglycemia (glucose level > 150mg/dL) (1) Yes (2) No 
4. Site for blood collection 
a. Heel stick 
b. UAC 
c. UVC 
Intraoperative blood glucose level: 
1. ACCUCHECK VALUE___ or Serum Value_______ 
2. Normal (glucose level 40-150 mg/dL): ________mg/dL 
3. Normoglycemia (glucose level 40-150 mg/dL) (1) Yes (2) No  
4. Abnormal (glucose level < 40 or > 150 mg/dL): _______mg/dL 
a. Hypoglycemia (glucose level <40 mg/dL) (1) Yes (2) No  
b. Hyperglycemia (glucose level > 150mg/dL) (1) Yes (2) No 
5. Site for blood collection 
a. Heel stick___ 
b. UAC___ 
c. UVC____ 
Proxy measure of intraoperative blood glucose level: 
1. ACCUCHECK VALUE_____   or Serum Value_______ 
2. Normal (glucose level 40-150 mg/dL): ________mg/dL 
a. Normoglycemia (glucose level 40-150 mg/dL) (1) Yes (2) No 
3. Abnormal (glucose level < 40 or > 150 mg/dL): _______mg/dL 
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a. Hypoglycemia (glucose level <40 mg/dL) (1) Yes (2) No  
Hyperglycemia (glucose level > 150mg/dL) (1) Yes (2) No 
4. Site for blood collection 
a. Heel stick___ 
b. UAC___ 
c. UVC____ 
Preoperative events: 
Preoperative acidosis: pH < 7.30 (1) Yes (2) No 
Preoperative hypobicarbonatemia: Bicarbonate < 19mEq/L (1) Yes (2) No  
Preoperative hypercarbia: PCO2 > 45 mmHg (1) Yes (2) No 
Neonatal physiological characteristics 
Intraoperative events: 
1. Intraoperative hypothermia: <37˚C  (1) Yes (2) No  
2. Intraoperative desaturation: SaO2 < 90% (1) Yes (2) No 
3. Intraoperative acidosis: pH < 7.30 (1) Yes (2) No 
4. Intraoperative hypobicarbonatemia: Bicarbonate < 19mEq/L (1) Yes (2) No  
5.Intraoperative hypercarbia: PCO2 > 45 mmHg (1) Yes (2) No  
Postoperative events:  
      1.Postoperative acidosis: pH < 7.30 (1) Yes (2) No  
      2. Postoperative hypobicarbonatemia: Bicarbonate < 19mEq/L (1) Yes (2) No 
      3. Postoperative hypercarbia: PCO2 > 45 mmHg (1) Yes (2)  
      4. Postoperative complications during first 24h postoperative period 
a. bleeding 
b. sepsis 
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c. Necrotizing enterocolitis 
d. Bronchopulmonary dysplasia 
e. Pulmonary hypertension 
f. Intraventricular hemorrhage 
Anesthesia provider resuscitation measures 
1. Intraoperative endotracheal tube placement: (1) Yes (2) No 
2. Intraoperative crystalloids administration: (1) Dextrose (2) Saline  
3. Intraoperative colloids administration: Albumin 2.5% (1) Yes (2) No 
4. Intraoperative blood product administration: (1) PRBCs (2) platelets (3) FFP  
5. Intraoperative vasopressor administration:  (1) Epinephrine (2) Ephedrine (3) 
Neosynephrine, (4) Dopamine  
Anesthesia provider resuscitation measures: 
6. Intraoperative anticholinergic administration: (1) Atropine (2) Glycopyrrolate 
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